William J. Jagust
#86,059
Most Influential Person Now
Researcher
William J. Jagust's AcademicInfluence.com Rankings
William J. Jagustphilosophy Degrees
Philosophy
#3084
World Rank
#5065
Historical Rank
Logic
#942
World Rank
#1533
Historical Rank
William J. Jagustbiology Degrees
Biology
#3731
World Rank
#5668
Historical Rank
Neuroscience
#357
World Rank
#374
Historical Rank
Download Badge
Philosophy Biology
William J. Jagust's Degrees
- PhD Neuroscience University of California, Berkeley
- Doctorate Medicine University of California, San Francisco
Why Is William J. Jagust Influential?
(Suggest an Edit or Addition)William J. Jagust's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- The diagnosis of mild cognitive impairment due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease (2011) (6818)
- NIA-AA Research Framework: Toward a biological definition of Alzheimer’s disease (2018) (4523)
- Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade (2010) (3896)
- Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers (2013) (3207)
- The Alzheimer's disease neuroimaging initiative. (2005) (3069)
- Criteria for the diagnosis of ischemic vascular dementia proposed by the State of California Alzheimer's Disease Diagnostic and Treatment Centers (1992) (1150)
- Prevalence of cerebral amyloid pathology in persons without dementia: a meta-analysis. (2015) (1112)
- Alzheimer's Disease Neuroimaging Initiative (2008) (1024)
- A/T/N: An unbiased descriptive classification scheme for Alzheimer disease biomarkers (2016) (1004)
- Ways toward an early diagnosis in Alzheimer’s disease: The Alzheimer’s Disease Neuroimaging Initiative (ADNI) (2005) (970)
- Positron emission tomography in evaluation of dementia: Regional brain metabolism and long-term outcome. (2001) (863)
- PET Imaging of Tau Deposition in the Aging Human Brain (2016) (804)
- Tau PET patterns mirror clinical and neuroanatomical variability in Alzheimer's disease. (2016) (765)
- Early role of vascular dysregulation on late-onset Alzheimer's disease based on multifactorial data-driven analysis (2016) (716)
- Alzheimer's Disease Neuroimaging Initiative (ADNI) (2010) (712)
- Magnetic resonance imaging of the entorhinal cortex and hippocampus in mild cognitive impairment and Alzheimer's disease (2001) (683)
- Prevalence and classification of mild cognitive impairment in the Cardiovascular Health Study Cognition Study: part 1. (2003) (639)
- Episodic memory loss is related to hippocampal-mediated beta-amyloid deposition in elderly subjects. (2009) (632)
- Associations between cognitive, functional, and FDG-PET measures of decline in AD and MCI (2011) (615)
- Comparing predictors of conversion and decline in mild cognitive impairment (2010) (570)
- Pattern of cerebral hypoperfusion in Alzheimer disease and mild cognitive impairment measured with arterial spin-labeling MR imaging: initial experience. (2005) (568)
- The Alzheimer’s Disease Neuroimaging Initiative: A review of papers published since its inception (2012) (553)
- The Centiloid Project: Standardizing quantitative amyloid plaque estimation by PET (2015) (536)
- Amyloid deposition, hypometabolism, and longitudinal cognitive decline (2012) (534)
- FDG-PET improves accuracy in distinguishing frontotemporal dementia and Alzheimer's disease. (2007) (523)
- The Alzheimer's Disease Neuroimaging Initiative: A review of papers published since its inception (2012) (513)
- Context processing in older adults: evidence for a theory relating cognitive control to neurobiology in healthy aging. (2001) (503)
- Earliest accumulation of β-amyloid occurs within the default-mode network and concurrently affects brain connectivity (2017) (492)
- The Alzheimer's Disease Neuroimaging Initiative positron emission tomography core (2010) (491)
- Diffusion tensor imaging of cingulum fibers in mild cognitive impairment and Alzheimer disease (2007) (485)
- Risk factors for mild cognitive impairment in the Cardiovascular Health Study Cognition Study: part 2. (2003) (484)
- White matter lesions impair frontal lobe function regardless of their location (2004) (477)
- Prevalence of amyloid PET positivity in dementia syndromes: a meta-analysis. (2015) (476)
- The Alzheimer's Disease Neuroimaging Initiative: Progress report and future plans (2010) (473)
- Aβ amyloid and glucose metabolism in three variants of primary progressive aphasia (2008) (442)
- The diagnosis of mild cognitive impairment due to Alzheimer's disease: Recommendations from the National Institute on Aging and Alzheimer's Association workgroup (2011) (441)
- Relationships between biomarkers in aging and dementia (2009) (440)
- Dementia and Alzheimer's Disease Incidence in Relationship to Cardiovascular Disease in the Cardiovascular Health Study Cohort (2005) (438)
- Anatomical Mapping of White Matter Hyperintensities (WMH): Exploring the Relationships Between Periventricular WMH, Deep WMH, and Total WMH Burden (2005) (434)
- The Role of APOE ∊4 in Modulating Effects of Other Risk Factors for Cognitive Decline in Elderly Persons (1999) (424)
- Prefrontal atrophy, disrupted NREM slow waves, and impaired hippocampal-dependent memory in aging (2013) (421)
- The measurement of everyday cognition (ECog): scale development and psychometric properties. (2008) (403)
- Tau pathology and neurodegeneration contribute to cognitive impairment in Alzheimer’s disease (2017) (402)
- Incidence and Prevalence of Dementia in the Cardiovascular Health Study (2004) (400)
- Hippocampal and cortical atrophy predict dementia in subcortical ischemic vascular disease (2000) (395)
- Clinical core of the Alzheimer's disease neuroimaging initiative: Progress and plans (2010) (395)
- Prevalence of Dementia in Older Latinos: The Influence of Type 2 Diabetes Mellitus, Stroke and Genetic Factors (2003) (387)
- Convection-Enhanced Delivery of AAV Vector in Parkinsonian Monkeys; In Vivo Detection of Gene Expression and Restoration of Dopaminergic Function Using Pro-drug Approach (2000) (380)
- β-amyloid disrupts human NREM slow waves and related hippocampus-dependent memory consolidation (2015) (373)
- The behavioural/dysexecutive variant of Alzheimer's disease: clinical, neuroimaging and pathological features. (2015) (370)
- Quantitative NMR measurements of hippocampal atrophy in Alzheimer's disease (1988) (363)
- Striatal Dopamine Predicts Outcome-Specific Reversal Learning and Its Sensitivity to Dopaminergic Drug Administration (2009) (350)
- Amyloid-β Imaging with Pittsburgh Compound B and Florbetapir: Comparing Radiotracers and Quantification Methods (2013) (349)
- 11C-PIB PET imaging in Alzheimer disease and frontotemporal lobar degeneration (2007) (347)
- Update on the biomarker core of the Alzheimer's Disease Neuroimaging Initiative subjects (2010) (311)
- Comparing positron emission tomography imaging and cerebrospinal fluid measurements of β‐amyloid (2013) (300)
- Neuropathologic Substrates of Ischemic Vascular Dementia (2000) (299)
- Longitudinal volumetric MRI change and rate of cognitive decline (2005) (299)
- Existing Pittsburgh Compound-B positron emission tomography thresholds are too high: statistical and pathological evaluation. (2015) (298)
- Anosognosia in Alzheimer's disease: relationships to depression, cognitive function, and cerebral perfusion. (1993) (296)
- Comparison of multiple tau-PET measures as biomarkers in aging and Alzheimer's disease (2017) (296)
- Central obesity and the aging brain. (2005) (293)
- Sleep: A Novel Mechanistic Pathway, Biomarker, and Treatment Target in the Pathology of Alzheimer's Disease? (2016) (293)
- MRI predictors of cognition in subcortical ischemic vascular disease and Alzheimer’s disease (2001) (292)
- What does fluorodeoxyglucose PET imaging add to a clinical diagnosis of dementia? (2007) (291)
- 2014 Update of the Alzheimer's Disease Neuroimaging Initiative: A review of papers published since its inception (2015) (287)
- Vulnerable Neural Systems and the Borderland of Brain Aging and Neurodegeneration (2013) (286)
- Association of lifetime cognitive engagement and low β-amyloid deposition. (2012) (285)
- Relationships between β-amyloid and functional connectivity in different components of the default mode network in aging. (2011) (285)
- Diverging patterns of amyloid deposition and hypometabolism in clinical variants of probable Alzheimer's disease. (2013) (282)
- Prospective longitudinal atrophy in Alzheimer’s disease correlates with the intensity and topography of baseline tau-PET (2020) (275)
- Subjective cognition and amyloid deposition imaging: a Pittsburgh Compound B positron emission tomography study in normal elderly individuals. (2012) (273)
- Categorical and correlational analyses of baseline fluorodeoxyglucose positron emission tomography images from the Alzheimer's Disease Neuroimaging Initiative (ADNI) (2009) (271)
- Degree of discrepancy between self and other‐reported everyday functioning by cognitive status: dementia, mild cognitive impairment, and healthy elders (2005) (270)
- Amyloid vs FDG-PET in the differential diagnosis of AD and FTLD (2011) (269)
- Imaging the evolution and pathophysiology of Alzheimer disease (2018) (268)
- Working Memory Capacity Predicts Dopamine Synthesis Capacity in the Human Striatum (2008) (267)
- Striatal dopamine and working memory. (2009) (267)
- Neuropathological basis of magnetic resonance images in aging and dementia (2008) (264)
- Computer-based Cognitive Training for Mild Cognitive Impairment: Results from a Pilot Randomized, Controlled Trial (2009) (262)
- Old Brains Come Uncoupled in Sleep: Slow Wave-Spindle Synchrony, Brain Atrophy, and Forgetting (2018) (255)
- Homocysteine, B vitamins, and the incidence of dementia and cognitive impairment: results from the Sacramento Area Latino Study on Aging. (2007) (254)
- Profiles of neuropsychological impairment in autopsy-defined Alzheimer's disease and cerebrovascular disease. (2007) (251)
- Clinical criteria for the diagnosis of vascular dementia: a multicenter study of comparability and interrater reliability. (2000) (249)
- Increased metabolic vulnerability in early-onset Alzheimer's disease is not related to amyloid burden. (2010) (245)
- SPECT perfusion imaging in the diagnosis of Alzheimer’s disease (2001) (241)
- Measurement of Longitudinal β-Amyloid Change with 18F-Florbetapir PET and Standardized Uptake Value Ratios (2015) (240)
- The role of APOE epsilon4 in modulating effects of other risk factors for cognitive decline in elderly persons. (1999) (237)
- Cognitive impact of subcortical vascular and Alzheimer's disease pathology (2006) (233)
- The diagnosis of dementia with single photon emission computed tomography. (1987) (232)
- Understanding disease progression and improving Alzheimer's disease clinical trials: Recent highlights from the Alzheimer's Disease Neuroimaging Initiative (2018) (225)
- Suspected non-Alzheimer disease pathophysiology — concept and controversy (2016) (224)
- Amyloid Imaging in Aging and Dementia: Testing the Amyloid Hypothesis In Vivo (2009) (222)
- Amyloid PET imaging in Alzheimer’s disease: a comparison of three radiotracers (2014) (218)
- Recent publications from the Alzheimer's Disease Neuroimaging Initiative: Reviewing progress toward improved AD clinical trials (2017) (214)
- Age effects on atrophy rates of entorhinal cortex and hippocampus (2006) (213)
- Changes of hippocampal N-acetyl aspartate and volume in Alzheimer's disease (1997) (212)
- Independent information from cerebrospinal fluid amyloid-β and florbetapir imaging in Alzheimer's disease. (2015) (211)
- Memory impairment, but not cerebrovascular disease, predicts progression of MCI to dementia (2004) (209)
- Estrogen- and tamoxifen-associated effects on brain structure and function (2004) (209)
- White Matter Changes Compromise Prefrontal Cortex Function in Healthy Elderly Individuals (2006) (208)
- The Alzheimer's Disease Neuroimaging Initiative 3: Continued innovation for clinical trial improvement (2017) (206)
- Basal forebrain degeneration precedes and predicts the cortical spread of Alzheimer's pathology (2016) (201)
- Associations between serum cholesterol levels and cerebral amyloidosis. (2014) (201)
- Four distinct trajectories of tau deposition identified in Alzheimer’s disease (2021) (200)
- Brain imaging evidence of preclinical Alzheimer's disease in normal aging (2006) (199)
- Alcohol Consumption Induces Endogenous Opioid Release in the Human Orbitofrontal Cortex and Nucleus Accumbens (2012) (198)
- Diminished Glucose Transport in Alzheimer's Disease: Dynamic PET Studies (1991) (188)
- Lifespan brain activity, β-amyloid, and Alzheimer's disease (2011) (187)
- The Influence of Latent Viral Infection on Rate of Cognitive Decline over 4 Years (2006) (186)
- APOE and BCHE as modulators of cerebral amyloid deposition: a florbetapir PET genome-wide association study (2013) (184)
- The EADC-ADNI Harmonized Protocol for manual hippocampal segmentation on magnetic resonance: Evidence of validity (2015) (182)
- Survival following dementia onset: Alzheimer's disease and vascular dementia (2005) (181)
- Low folate status is associated with impaired cognitive function and dementia in the Sacramento Area Latino Study on Aging. (2005) (179)
- Neuropsychological characteristics of mild cognitive impairment subgroups (2005) (177)
- Rate of progression differs in frontotemporal dementia and Alzheimer disease (2005) (176)
- Impact of the Alzheimer's Disease Neuroimaging Initiative, 2004 to 2014 (2015) (175)
- Atrophy patterns in early clinical stages across distinct phenotypes of Alzheimer's disease (2015) (175)
- Factors affecting Aβ plasma levels and their utility as biomarkers in ADNI (2011) (175)
- Homocysteine, vitamin B6, and vascular disease in AD patients (2002) (174)
- Imaging markers for Alzheimer disease (2013) (174)
- Higher atrophy rate of entorhinal cortex than hippocampus in AD (2004) (173)
- Associations between Alzheimer disease biomarkers, neurodegeneration, and cognition in cognitively normal older people. (2013) (170)
- Utility of clinical criteria in differentiating frontotemporal lobar degeneration (FTLD) from AD (2002) (170)
- The Alzheimer's Disease Neuroimaging Initiative 2 PET Core: 2015 (2015) (170)
- Longitudinal change of biomarkers in cognitive decline. (2011) (169)
- Cerebral blood flow in ischemic vascular dementia and Alzheimer's disease, measured by arterial spin-labeling magnetic resonance imaging (2009) (168)
- Determinants of vascular dementia in the Cardiovascular Health Cognition Study (2005) (167)
- Effects of white matter lesions and lacunes on cortical function. (2004) (166)
- Longitudinal tau accumulation and atrophy in aging and alzheimer disease (2019) (165)
- Entorhinal Tau Pathology, Episodic Memory Decline, and Neurodegeneration in Aging (2017) (164)
- Longitudinal studies of regional cerebral metabolism in Alzheimer's disease (1988) (161)
- Ferritin levels in the cerebrospinal fluid predict Alzheimer's disease outcomes and are regulated by APOE (2015) (161)
- Considerations and code for partial volume correcting [18F]-AV-1451 tau PET data (2017) (161)
- Neural compensation in older people with brain β-amyloid deposition (2014) (155)
- Twelve-month metabolic declines in probable Alzheimer's disease and amnestic mild cognitive impairment assessed using an empirically pre-defined statistical region-of-interest: Findings from the Alzheimer's Disease Neuroimaging Initiative (2010) (153)
- Characterizing Alzheimer's disease using a hypometabolic convergence index (2011) (145)
- Alzheimer's Disease Neurodegenerative Biomarkers Are Associated with Decreased Cognitive Function but Not β-Amyloid in Cognitively Normal Older Individuals (2013) (145)
- Association of brain amyloid-β with cerebral perfusion and structure in Alzheimer's disease and mild cognitive impairment. (2014) (144)
- Apolipoprotein E, Not Fibrillar β-Amyloid, Reduces Cerebral Glucose Metabolism in Normal Aging (2012) (143)
- Vascular burden and Alzheimer disease pathologic progression (2012) (143)
- Not quite PIB-positive, not quite PIB-negative: Slight PIB elevations in elderly normal control subjects are biologically relevant (2012) (142)
- Homocysteine and cognitive function in the Sacramento Area Latino Study on Aging. (2003) (140)
- APOE effect on Alzheimer's disease biomarkers in older adults with significant memory concern (2015) (138)
- Cognition, glucose metabolism and amyloid burden in Alzheimer's disease (2012) (138)
- The role of apolipoprotein E (APOE) genotype in early mild cognitive impairment (E-MCI) (2013) (137)
- Selective reduction of N-acetylaspartate in medial temporal and parietal lobes in AD (2002) (136)
- Predicting Alzheimer’s disease progression using multi-modal deep learning approach (2019) (136)
- Association Between Anticholinergic Medication Use and Cognition, Brain Metabolism, and Brain Atrophy in Cognitively Normal Older Adults. (2016) (133)
- Biomarkers for tau pathology (2019) (132)
- Aβ Deposition in aging is associated with increases in brain activation during successful memory encoding. (2012) (128)
- The aging brain and cognition: contribution of vascular injury and aβ to mild cognitive dysfunction. (2013) (127)
- 3D PIB and CSF biomarker associations with hippocampal atrophy in ADNI subjects (2010) (126)
- Volumetric MRI predicts rate of cognitive decline related to AD and cerebrovascular disease (2002) (126)
- Fluency and memory differences between ischemic vascular dementia and Alzheimer's disease. (1997) (126)
- Cerebrovascular disease, beta-amyloid, and cognition in aging (2012) (126)
- 18F‐flortaucipir tau positron emission tomography distinguishes established progressive supranuclear palsy from controls and Parkinson disease: A multicenter study (2017) (124)
- Brain structure and cognition in a community sample of elderly Latinos (2002) (123)
- Different mechanisms of episodic memory failure in mild cognitive impairment (2005) (122)
- Impaired prefrontal sleep spindle regulation of hippocampal-dependent learning in older adults. (2014) (121)
- Effects of subcortical ischemic vascular dementia and AD on entorhinal cortex and hippocampus (2002) (121)
- Improved Power for Characterizing Longitudinal Amyloid-β PET Changes and Evaluating Amyloid-Modifying Treatments with a Cerebral White Matter Reference Region (2015) (118)
- Multisite study of the relationships between antemortem [11C]PIB-PET Centiloid values and postmortem measures of Alzheimer's disease neuropathology (2018) (118)
- Tau, amyloid, and hypometabolism in a patient with posterior cortical atrophy (2015) (118)
- Association of Cerebral Amyloid-&bgr; Aggregation With Cognitive Functioning in Persons Without Dementia (2018) (116)
- White matter lesions are associated with cortical atrophy more than entorhinal and hippocampal atrophy (2004) (116)
- Regional cerebral glucose transport and utilization in Alzheimer's disease (1989) (115)
- Mental status as a predictor of daily function in progressive dementia. (1989) (114)
- Dopamine Supports Coupling of Attention-Related Networks (2012) (114)
- Intrinsic connectivity networks in healthy subjects explain clinical variability in Alzheimer’s disease (2013) (113)
- Sleep as a Potential Biomarker of Tau and β-Amyloid Burden in the Human Brain (2019) (110)
- Preliminary evidence that estrogen protects against age-related hippocampal atrophy (2003) (110)
- Update on hypothetical model of Alzheimer's disease biomarkers (2013) (109)
- Local and distant relationships between amyloid, tau and neurodegeneration in Alzheimer's Disease (2017) (109)
- GWAS of longitudinal amyloid accumulation on 18F-florbetapir PET in Alzheimer's disease implicates microglial activation gene IL1RAP. (2015) (108)
- The effects of age on rate of progression of Alzheimer disease and dementia with associated cerebrovascular disease. (2001) (108)
- Brain imaging in the study of Alzheimer's disease (2012) (108)
- β-Amyloid affects frontal and posterior brain networks in normal aging (2011) (107)
- Associations between [18F]AV1451 tau PET and CSF measures of tau pathology in a clinical sample (2017) (105)
- Differences in lateral hemispheric asymmetries of glucose utilization between early- and late-onset Alzheimer-type dementia. (1985) (105)
- Human corpus callosum in aging and alzheimer's disease: a magnetic resonance imaging study (1994) (105)
- Effects of subcortical cerebral infarction on cortical glucose metabolism and cognitive function. (1999) (104)
- 18F-flortaucipir (AV-1451) tau PET in frontotemporal dementia syndromes (2019) (104)
- Hexanucleotide repeat expansions in C9ORF72 in the spectrum of motor neuron diseases (2012) (104)
- Gene–Environment Interactions: Lifetime Cognitive Activity, APOE Genotype, and Beta-Amyloid Burden (2014) (104)
- Cardiovascular risk factors, cortisol, and amyloid-β deposition in Alzheimer's Disease Neuroimaging Initiative (2012) (103)
- Amyloid negativity in patients with clinically diagnosed Alzheimer disease and MCI (2016) (103)
- Cortical glucose metabolism in Parkinson's disease without dementia (1994) (103)
- Neuroprotective pathways: lifestyle activity, brain pathology, and cognition in cognitively normal older adults (2014) (102)
- Spatial patterns of brain amyloid-beta burden and atrophy rate associations in mild cognitive impairment. (2011) (101)
- Memory decline accompanies subthreshold amyloid accumulation (2018) (101)
- Clinical Studies of Cerebral Blood Flow in Alzheimer's Disease (1997) (100)
- Focal Alzheimer's disease (1990) (99)
- Reduced temporal lobe blood flow in alzheimer's disease (1992) (98)
- Regional brain hypometabolism is unrelated to regional amyloid plaque burden. (2015) (98)
- A comparison of classification methods for differentiating fronto‐temporal dementia from Alzheimer's disease using FDG‐PET imaging (2004) (97)
- The influence of biological and technical factors on quantitative analysis of amyloid PET: Points to consider and recommendations for controlling variability in longitudinal data (2015) (97)
- Advances in neuroimaging of traumatic brain injury and posttraumatic stress disorder. (2009) (97)
- Functional brain architecture is associated with the rate of tau accumulation in Alzheimer’s disease (2020) (96)
- Clinical-physiologic correlates of Alzheimer's disease and frontal lobe dementia. (1989) (96)
- Positron emission tomography with [18F]fluorodeoxyglucose differentiates normal pressure hydrocephalus from Alzheimer-type dementia. (1985) (95)
- CSF biomarker and PIB-PET–derived beta-amyloid signature predicts metabolic, grey matter and cognitive changes in nondemented subjects (2011) (95)
- Aging Affects Dopaminergic Neural Mechanisms of Cognitive Flexibility (2016) (95)
- Tau and β-Amyloid Are Associated with Medial Temporal Lobe Structure, Function, and Memory Encoding in Normal Aging (2017) (93)
- Relationship of Striatal Dopamine Synthesis Capacity to Age and Cognition (2008) (93)
- Diagnostic accuracy of CSF Ab42 and florbetapir PET for Alzheimer's disease (2014) (93)
- Increased Striatal Dopamine Synthesis Capacity in Gambling Addiction (2017) (92)
- Subthreshold Amyloid Predicts Tau Deposition in Aging (2018) (92)
- Comparison of methods for measuring longitudinal brain change in cognitive impairment and dementia (2003) (92)
- Neuronal injury biomarkers and prognosis in ADNI subjects with normal cognition (2014) (91)
- 11 CPIB PET imaging in Alzheimer disease and frontotemporal lobar degeneration (2007) (90)
- Effects of Beta-Amyloid on Resting State Functional Connectivity Within and Between Networks Reflect Known Patterns of Regional Vulnerability. (2014) (90)
- Nonlinear Association Between Cerebrospinal Fluid and Florbetapir F-18 β-Amyloid Measures Across the Spectrum of Alzheimer Disease. (2015) (89)
- Association between tau deposition and antecedent amyloid-&bgr; accumulation rates in normal and early symptomatic individuals (2017) (88)
- Alzheimer's pathology targets distinct memory networks in the ageing brain. (2019) (87)
- Cognitive function and regional cerebral blood flow in Parkinson's disease. (1992) (85)
- Vascular risk and Aβ interact to reduce cortical thickness in AD vulnerable brain regions (2014) (85)
- Using Pittsburgh Compound B for in vivo PET imaging of fibrillar amyloid-beta. (2012) (84)
- Summary Metrics to Assess Alzheimer Disease–Related Hypometabolic Pattern with 18F-FDG PET: Head-to-Head Comparison (2012) (84)
- Overeating Behavior and Striatal Dopamine with 6-[18F]-Fluoro-L-m-Tyrosine PET (2010) (84)
- Accuracy of Tau Positron Emission Tomography as a Prognostic Marker in Preclinical and Prodromal Alzheimer Disease (2021) (83)
- Associations between White Matter Hyperintensities and β Amyloid on Integrity of Projection, Association, and Limbic Fiber Tracts Measured with Diffusion Tensor MRI (2013) (82)
- Covarying alterations in Aβ deposition, glucose metabolism, and gray matter volume in cognitively normal elderly (2014) (81)
- Is amyloid-β harmful to the brain? Insights from human imaging studies. (2016) (80)
- Functional Neuroimaging of Cortical Dysfunction in Alcoholic Korsakoff's Syndrome (1997) (80)
- Reduced medial temporal lobe N-acetylaspartate in cognitively impaired but nondemented patients (2005) (80)
- The MRI brain correlates of depressed mood, anhedonia, apathy, and anergia in older adults with and without cognitive impairment or dementia (2008) (79)
- Dynamic PET Measures of Tau Accumulation in Cognitively Normal Older Adults and Alzheimer’s Disease Patients Measured Using [18F] THK-5351 (2016) (78)
- Reference Tissue–Based Kinetic Evaluation of 18F-AV-1451 for Tau Imaging (2017) (78)
- Memory and regional cerebral blood flow in mildly symptomatic Alzheimer's disease (1989) (78)
- Performance of FDG PET for Detection of Alzheimer’s Disease in Two Independent Multicentre Samples (NEST-DD and ADNI) (2009) (77)
- Frontotemporal dementia with the V337M MAPT mutation (2017) (77)
- Temporoparietal hypometabolism in frontotemporal lobar degeneration and associated imaging diagnostic errors. (2011) (76)
- Hippocampal activation is associated with longitudinal amyloid accumulation and cognitive decline (2017) (76)
- Positron emission tomography and magnetic resonance imaging in the diagnosis and prediction of dementia (2006) (76)
- Early 11C-PIB Frames and 18F-FDG PET Measures Are Comparable: A Study Validated in a Cohort of AD and FTLD Patients (2011) (75)
- Association of gray matter atrophy with age, β-amyloid, and cognition in aging. (2014) (74)
- Non-coding variability at the APOE locus contributes to the Alzheimer’s risk (2019) (74)
- Temporal lobe perfusion on single photon emission computed tomography predicts the rate of cognitive decline in Alzheimer's disease. (1995) (73)
- The cortical topography of temporal lobe hypometabolism in early Alzheimer's disease (1993) (73)
- Dopamine and frontostriatal networks in cognitive aging (2012) (72)
- Effects of Alzheimer Disease on Fronto-parietal Brain N-acetyl Aspartate and Myo-Inositol Using Magnetic Resonance Spectroscopic Imaging (2006) (72)
- Effect of Cognitive Reserve Markers on Alzheimer Pathologic Progression (2013) (72)
- Association of Serum Docosahexaenoic Acid With Cerebral Amyloidosis. (2016) (72)
- Rates of Amyloid Imaging Positivity in Patients With Primary Progressive Aphasia (2018) (71)
- The practical utility of amyloid and FDG-PET in an academic dementia center (2013) (70)
- Effect of Off-Target Binding on 18F-Flortaucipir Variability in Healthy Controls Across the Life Span (2019) (70)
- Coronary risk correlates with cerebral amyloid deposition (2012) (70)
- 18F-flortaucipir PET to autopsy comparisons in Alzheimer's disease and other neurodegenerative diseases. (2020) (70)
- Assessment of Extent and Role of Tau in Subcortical Vascular Cognitive Impairment Using 18F-AV1451 Positron Emission Tomography Imaging (2018) (70)
- Robust Identification of Alzheimer’s Disease subtypes based on cortical atrophy patterns (2017) (69)
- Visuoconstructive performance and regional cerebral glucose metabolism in Alzheimer's disease. (1991) (68)
- Association of depressed mood and mortality in older adults with and without cognitive impairment in a prospective naturalistic study. (2010) (68)
- A pilot study of vitamins to lower plasma homocysteine levels in Alzheimer disease. (2003) (67)
- Imaging biomarkers in neurodegeneration: current and future practices (2020) (67)
- Hippocampal volume and retention in Alzheimer's disease (2004) (67)
- Brain Behavior Relationships Among African Americans, Whites, and Hispanics (2008) (66)
- Amyloid and tau PET demonstrate region-specific associations in normal older people (2017) (66)
- Loss of functional connectivity is greater outside the default mode network in nonfamilial early-onset Alzheimer's disease variants (2015) (66)
- Sleep Disturbance Forecasts β-Amyloid Accumulation across Subsequent Years (2020) (65)
- Time to Amyloid Positivity and Preclinical Changes in Brain Metabolism, Atrophy, and Cognition: Evidence for Emerging Amyloid Pathology in Alzheimer's Disease (2017) (65)
- Everyday functioning in relation to cognitive functioning and neuroimaging in community-dwelling Hispanic and Non-Hispanic older adults (2004) (65)
- Diagnostic accuracy of markers for prodromal Alzheimer's disease in independent clinical series (2013) (63)
- Atrophy, hypometabolism and clinical trajectories in patients with amyloid-negative Alzheimer's disease. (2016) (63)
- The effect of amyloid β on cognitive decline is modulated by neural integrity in cognitively normal elderly (2013) (62)
- Positron Emission Tomography in Evaluation of Dementia (2001) (62)
- Subcortical ischemic vascular dementia: assessment with quantitative MR imaging and 1H MR spectroscopy. (2000) (62)
- Alzheimer's disease. Age at onset and single-photon emission computed tomographic patterns of regional cerebral blood flow. (1990) (61)
- Comparisons between Global and Focal Brain Atrophy Rates in Normal Aging and Alzheimer Disease: Boundary Shift Integral versus Tracing of the Entorhinal Cortex and Hippocampus (2004) (60)
- C-reactive protein and rate of dementia in carriers and non carriers of Apolipoprotein APOE4 genotype (2008) (60)
- Dynamic relationships between age, amyloid-β deposition, and glucose metabolism link to the regional vulnerability to Alzheimer's disease. (2016) (60)
- Dissociable effects of Alzheimer disease and white matter hyperintensities on brain metabolism. (2013) (60)
- Comparison of Visual and Quantitative Florbetapir F 18 Positron Emission Tomography Analysis in Predicting Mild Cognitive Impairment Outcomes. (2015) (59)
- Association of common genetic variants in GPCPD1 with scaling of visual cortical surface area in humans (2012) (59)
- Effect of estrogen on cerebral glucose metabolism in postmenopausal women (2000) (58)
- Frontotemporal Network Connectivity during Memory Encoding Is Increased with Aging and Disrupted by Beta-Amyloid (2013) (58)
- Longitudinal measurement and hierarchical classification framework for the prediction of Alzheimer’s disease (2017) (58)
- Parallel ICA of FDG-PET and PiB-PET in three conditions with underlying Alzheimer's pathology (2014) (58)
- Amyloid imaging in distinguishing atypical prion disease from Alzheimer disease (2007) (58)
- Cortical tau deposition follows patterns of entorhinal functional connectivity in aging (2019) (58)
- Automatic semantic priming with various category relations in Alzheimer's disease and normal aging. (1991) (57)
- Correlations of striatal dopamine synthesis with default network deactivations during working memory in younger adults (2011) (57)
- 6-[18F]Fluoro-l-m-tyrosine: metabolism, positron emission tomography kinetics, and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine lesions in primates (1997) (57)
- Challenges and Opportunities with Causal Discovery Algorithms: Application to Alzheimer’s Pathophysiology (2020) (56)
- Iodine-123-5-iodo-6-nitroquipazine: SPECT radiotracer to image the serotonin transporter. (1996) (56)
- Automatic semantic priming with various category relations in Alzheimer's disease and normal aging (1991) (56)
- Magnetization transfer ratio of white matter hyperintensities in subcortical ischemic vascular dementia. (1999) (56)
- F-Flortaucipir Tau Positron Emission Tomography Distinguishes Established Progressive Supranuclear Palsy from Controls and Parkinson Disease: A Multicenter Study (2017) (56)
- Neuropsychiatric subsyndromes and brain metabolic network dysfunctions in early onset Alzheimer's disease (2016) (56)
- Dopamine and the Cognitive Downside of a Promised Bonus (2014) (56)
- Effects of traumatic brain injury and posttraumatic stress disorder on Alzheimer’s disease in veterans, using the Alzheimer’s Disease Neuroimaging Initiative (2014) (55)
- Associations Among Vascular Risk Factors, Carotid Atherosclerosis, and Cortical Volume and Thickness in Older Adults (2012) (54)
- Temporal Lobe Metabolic Differences in Medication-Free Outpatients with Schizophrenia via the PET-600 (1996) (53)
- Spontaneous eye blink rate and dopamine synthesis capacity: preliminary evidence for an absence of positive correlation (2017) (53)
- The Use of MRI and PET for Clinical Diagnosis of Dementia and Investigation of Cognitive Impairment : A Consensus Report (2004) (52)
- The BIN1 rs744373 SNP is associated with increased tau-PET levels and impaired memory (2019) (52)
- Amyloid pathway-based candidate gene analysis of [11C]PiB-PET in the Alzheimer’s Disease Neuroimaging Initiative (ADNI) cohort (2011) (52)
- Aβ Imaging: feasible, pertinent, and vital to progress in Alzheimer’s disease (2012) (52)
- White matter integrity and cortical metabolic associations in aging and dementia (2010) (52)
- Prevalence of the apolipoprotein E ε4 allele in amyloid β positive subjects across the spectrum of Alzheimer's disease (2017) (52)
- Tau deposition is associated with functional isolation of the hippocampus in aging (2019) (52)
- Focal hemosiderin deposits and β-amyloid load in the ADNI cohort (2013) (51)
- Striatal Dopamine Influences the Default Mode Network to Affect Shifting between Object Features (2012) (51)
- Relationships Between Tau and Glucose Metabolism Reflect Alzheimer's Disease Pathology in Cognitively Normal Older Adults. (2019) (51)
- Automated template-based PET region of interest analyses in the aging brain (2007) (50)
- Greater medial temporal hypometabolism and lower cortical amyloid burden in ApoE4-positive AD patients (2013) (50)
- Cortical sources of resting state EEG rhythms are related to brain hypometabolism in subjects with Alzheimer's disease: an EEG-PET study (2016) (50)
- Regional correlations between [11C]PIB PET and post-mortem burden of amyloid-beta pathology in a diverse neuropathological cohort (2016) (49)
- Accelerating rates of cognitive decline and imaging markers associated with β-amyloid pathology (2016) (49)
- Bitemporal hypometabolism in Creutzfeldt-Jakob disease measured by positron emission tomography with [18F]-2-fluorodeoxyglucose. (1984) (49)
- Subjective cognitive decline and β-amyloid burden predict cognitive change in healthy elderly (2017) (48)
- Predicting Reduction of Cerebrospinal Fluid β-Amyloid 42 in Cognitively Healthy Controls. (2015) (47)
- CSF biomarker associations with change in hippocampal volume and precuneus thickness: implications for the Alzheimer’s pathological cascade (2012) (47)
- Tau covariance patterns in Alzheimer's disease patients match intrinsic connectivity networks in the healthy brain (2019) (47)
- Cognitive and anatomic contributions of metabolic decline in Alzheimer disease and cerebrovascular disease. (2008) (46)
- A videotaped CIBIC for dementia patients: Validity and reliability in a simulated clinical trial (2002) (46)
- Brain morphology, cognition, and β-amyloid in older adults with superior memory performance (2018) (45)
- Untangling vascular dementia (2001) (45)
- An inverse association of cardiovascular risk and frontal lobe glucose metabolism (2009) (45)
- Associations Between Tau, &bgr;-Amyloid, and Cognition in Parkinson Disease (2017) (45)
- Head to head comparison of [18F] AV-1451 and [18F] THK5351 for tau imaging in Alzheimer’s disease and frontotemporal dementia (2017) (45)
- Imaging the aging brain (2009) (44)
- Prevalence Estimates of Amyloid Abnormality Across the Alzheimer Disease Clinical Spectrum. (2022) (44)
- Effect of CLU genetic variants on cerebrospinal fluid and neuroimaging markers in healthy, mild cognitive impairment and Alzheimer’s disease cohorts (2016) (44)
- BrainN-acetyl-l-aspartic acid in Alzheimer's disease: a proton magnetic resonance spectroscopy study (1994) (44)
- Brain perfusion imaging predicts survival in Alzheimer's disease (1998) (43)
- Functional Imaging Patterns in Alzheimer's Disease Relationships to Neurobiology a (1996) (41)
- Brain structure and function as mediators of the effects of amyloid on memory (2015) (41)
- In vivo imaging of the 5-hydroxytryptamine reuptake site in primate brain using single photon emission computed tomography and [123I]5-iodo-6-nitroquipazine. (1993) (41)
- A novel MPTP primate model of Parkinson's disease: neurochemical and clinical changes (1998) (41)
- Dopamine Synthesis Capacity is Associated with D2/3 Receptor Binding but Not Dopamine Release (2017) (41)
- Molecular neuroimaging in Alzheimer’s disease (2004) (41)
- Neurophysiological signatures in Alzheimer’s disease are distinctly associated with TAU, amyloid-β accumulation, and cognitive decline (2020) (40)
- Cerebral Glucose Metabolism and Memory in Aged Rhesus Macaques (1997) (40)
- What can imaging reveal about obesity and the brain? (2007) (40)
- Fraction of total plasma vitamin B12 bound to transcobalamin correlates with cognitive function in elderly Latinos with depressive symptoms. (2008) (39)
- Is verbal episodic memory in elderly with amyloid deposits preserved through altered neuronal function? (2014) (39)
- Brain amyloidosis ascertainment from cognitive, imaging, and peripheral blood protein measures (2015) (39)
- Role of positron emission tomography in determining the extent of CNS ischemia in patients with sickle cell disease (1999) (39)
- Diagnostic utility of ASL‐MRI and FDG‐PET in the behavioral variant of FTD and AD (2016) (39)
- Association of APOE4 and Clinical Variability in Alzheimer Disease With the Pattern of Tau- and Amyloid-PET (2020) (38)
- Effects of age and β-amyloid on cognitive changes in normal elderly people (2012) (38)
- Association of plasma and cortical amyloid beta is modulated by APOE ε4 status (2014) (38)
- Bilateral Thalamic Lesions Affect Recollection-and Familiarity-Based Recognition Memory Judgments (2005) (38)
- Modulation of impulsivity and reward sensitivity in intertemporal choice by striatal and midbrain dopamine synthesis in healthy adults. (2016) (37)
- The mediational effects of FDG hypometabolism on the association between cerebrospinal fluid biomarkers and neurocognitive function (2015) (37)
- Cortical thickness mediates the effect of β-amyloid on episodic memory (2014) (37)
- Longitudinal Cognitive and Biomarker Measurements Support a Unidirectional Pathway in Alzheimer’s Disease Pathophysiology (2020) (36)
- Mining Outcome-relevant Brain Imaging Genetic Associations via Three-way Sparse Canonical Correlation Analysis in Alzheimer’s Disease (2017) (36)
- Cognitive correlates of regional cerebral blood flow in Alzheimer's disease. (1993) (36)
- Tau PET and multimodal brain imaging in patients at risk for chronic traumatic encephalopathy (2019) (36)
- Plasma acetylcholinesterase activity correlates with intracerebral β-amyloid load. (2013) (35)
- Predicting Short-term MCI-to-AD Progression Using Imaging, CSF, Genetic Factors, Cognitive Resilience, and Demographics (2019) (35)
- Correlates of memory function in community-dwelling elderly: The importance of white matter hyperintensities (2004) (34)
- Method to correlate 1H MRSI and 18FDG‐PET (2000) (34)
- Detecting earlier stages of amyloid deposition using PET in cognitively normal elderly adults (2020) (34)
- Large-scale genomics unveil polygenic architecture of human cortical surface area (2015) (34)
- The diagnosis of Alzheimer-type dementia. A preliminary comparison of positron emission tomography and proton magnetic resonance. (1984) (34)
- Predicting missing biomarker data in a longitudinal study of Alzheimer disease (2012) (33)
- White Matter Structure in Older Adults Moderates the Benefit of Sleep Spindles on Motor Memory Consolidation (2017) (33)
- Modelling prognostic trajectories of cognitive decline due to Alzheimer's disease (2020) (33)
- Functional imaging in dementia: an overview. (1994) (33)
- Genetic effects on behavior are mediated by neurotransmitters and large-scale neural networks (2013) (32)
- Brain atrophy as a surrogate marker in MS (2000) (32)
- MRI, CT, SPECT, PET: their use in diagnosing dementia. (1991) (30)
- Association Between Common Variants in RBFOX1, an RNA-Binding Protein, and Brain Amyloidosis in Early and Preclinical Alzheimer Disease. (2020) (30)
- Elevated 18F-AV-1451 PET tracer uptake detected in incidental imaging findings (2017) (29)
- Discriminative Power of Arterial Spin Labeling Magnetic Resonance Imaging and 18F-Fluorodeoxyglucose Positron Emission Tomography Changes for Amyloid-β-Positive Subjects in the Alzheimer's Disease Continuum (2015) (29)
- Genetic studies of plasma analytes identify novel potential biomarkers for several complex traits (2016) (28)
- Before it is too late: professional responsibilities in late-onset Alzheimer’s research and pre-symptomatic prediction (2014) (28)
- Validation of consensus panel diagnosis in dementia. (2010) (28)
- Focal hemosiderin deposits and beta-amyloid load in the ADNI cohort (2013) (27)
- Impact of apolipoprotein ɛ4–cerebrospinal fluid beta-amyloid interaction on hippocampal volume loss over 1 year in mild cognitive impairment (2011) (27)
- Relevance of biomarkers across different neurodegenerative (2020) (27)
- Validation of amyloid PET positivity thresholds in centiloids: a multisite PET study approach (2021) (27)
- Detection of β-amyloid positivity in Alzheimer’s Disease Neuroimaging Initiative participants with demographics, cognition, MRI and plasma biomarkers (2021) (27)
- Imaging Vascular Disease and Amyloid in the Aging Brain: Implications for Treatment. (2015) (27)
- β-amyloid, hippocampal atrophy and their relation to longitudinal brain change in cognitively normal individuals (2016) (26)
- Clinical and Neuropsychological Features in Autopsy-Defined Vascular Dementia (2004) (26)
- Women can bear a bigger burden: ante- and post-mortem evidence for reserve in the face of tau (2020) (26)
- Longitudinal structural and metabolic changes in frontotemporal dementia (2020) (25)
- Dopamine transporter loss and clinical changes in MPTP-lesioned primates (1999) (25)
- Accelerated functional brain aging in pre-clinical familial Alzheimer’s disease (2021) (25)
- Neuroimaging in dementia. (2000) (25)
- Metabolic brain networks in aging and preclinical Alzheimer's disease (2017) (25)
- Dorsal Striatal Dopamine, Food Preference and Health Perception in Humans (2014) (24)
- Volumetric method for evaluating magnetization transfer ratio of tissue categories: application to areas of white matter signal hyperintensity in the elderly. (1997) (24)
- Genes and Cognitive Aging (2009) (24)
- Alzheimer Disease Signature Neurodegeneration and APOE Genotype in Mild Cognitive Impairment With Suspected Non–Alzheimer Disease Pathophysiology (2017) (24)
- Distinct effects of beta‐amyloid and tau on cortical thickness in cognitively healthy older adults (2020) (24)
- Low erythrocyte folate, but not plasma vitamin B-12 or homocysteine,is associated with dementia in elderly Latinos. (2005) (24)
- PET studies of cerebral glucose metabolism in conscious rhesus macaques (1995) (24)
- Subjective Cognition and Amyloid Deposition Imaging (2017) (24)
- Impact of lifestyle dimensions on brain pathology and cognition (2016) (23)
- SPECT Perfusion Imaging in the Diagnosis of Dementia (1995) (23)
- The Influence of Dopamine on Cognitive Flexibility Is Mediated by Functional Connectivity in Young but Not Older Adults (2018) (23)
- The Receiver Operational Characteristic for Binary Classification with Multiple Indices and Its Application to the Neuroimaging Study of Alzheimer's Disease (2013) (22)
- Using the Alzheimer's Disease Neuroimaging Initiative to improve early detection, diagnosis, and treatment of Alzheimer's disease (2021) (22)
- Association of vascular brain injury, neurodegeneration, amyloid, and cognitive trajectory (2020) (22)
- Dopaminergic Mechanisms Underlying Normal Variation in Trait Anxiety (2019) (22)
- Spatial Relationships between Molecular Pathology and Neurodegeneration in the Alzheimer's Disease Continuum. (2020) (22)
- “Alzheimer's disease” is neither “Alzheimer's clinical syndrome” nor “dementia” (2019) (21)
- 18F-florbetapir Positron Emission Tomography–determined Cerebral &bgr;-Amyloid Deposition and Neurocognitive Performance after Cardiac Surgery (2018) (21)
- Association of CSF Aβ, amyloid PET, and cognition in cognitively unimpaired elderly adults (2020) (21)
- Clinical evaluation of a high-resolution (2.6-mm) positron emission tomography. (1990) (20)
- Mapping brain β-amyloid (2009) (20)
- Diagnostic Accuracy of Amyloid versus 18F‐Fluorodeoxyglucose Positron Emission Tomography in Autopsy‐Confirmed Dementia (2020) (20)
- Cascaded Multi-view Canonical Correlation (CaMCCo) for Early Diagnosis of Alzheimer’s Disease via Fusion of Clinical, Imaging and Omic Features (2017) (20)
- KL-VS heterozygosity is associated with lower amyloid-dependent tau accumulation and memory impairment in Alzheimer’s disease (2021) (19)
- A Novel Joint Brain Network Analysis Using Longitudinal Alzheimer’s Disease Data (2019) (19)
- Vascular Burden Score Impacts Cognition Independent of Amyloid PET and MRI Measures of Alzheimer's Disease and Vascular Brain Injury. (2019) (19)
- Assessing the reliability to detect cerebral hypometabolism in probable Alzheimer's disease and amnestic mild cognitive impairment (2010) (18)
- Cortical hypometabolism reflects local atrophy and tau pathology in symptomatic Alzheimer's disease. (2021) (18)
- Catechol‐O‐Methyltransferase Genotype Modulates Opioid Release in Decision Circuitry (2013) (18)
- Temporal Dynamics of β-Amyloid Accumulation in Aging and Alzheimer Disease (2021) (18)
- Effect of extrapyramidal signs and Lewy bodies on survival in patients with Alzheimer disease. (2002) (17)
- Anatomical Mapping of White Matter Hyperintensities (WMH) (2004) (17)
- Spatial patterns of tau deposition are associated with amyloid, ApoE, sex, and cognitive decline in older adults (2020) (17)
- Methodologic factors affecting PET measurements of cerebral glucose metabolism. (1986) (17)
- Normalization of CSF pTau measurement by Aβ40 improves its performance as a biomarker of Alzheimer’s disease (2020) (17)
- Physical Activity and AD-Related Pathology-Reply. (2012) (17)
- Functional imaging, the frontal lobes, and dementia. (1998) (17)
- Single‐Photon Emission Computed Tomography Studies of Regional Cerebral Blood Flow in Multiple Infarct Dementia (1992) (16)
- Genome-wide association analysis of hippocampal volume identifies enrichment of neurogenesis-related pathways (2016) (16)
- Plasma phosphorylated-tau181 as a predictive biomarker for Alzheimer’s amyloid, tau and FDG PET status (2021) (16)
- PET 6-[18F]fluoro-L-m-tyrosine Studies of Dopaminergic Function in Human and Nonhuman Primates (2007) (16)
- Quantitative Magnetic Resonance Imaging Differences Between Alzheimer Disease With and Without Subcortical Lacunes (2002) (16)
- High resolution positron emission tomography for medical science studies. (1991) (15)
- Clustering-Initiated Factor Analysis Application for Tissue Classification in Dynamic Brain Positron Emission Tomography (2015) (15)
- 2017 NIA-AA RESEARCH FRAMEWORK TO INVESTIGATE THE ALZHEIMER’S DISEASE CONTINUUM (2017) (15)
- Regional Amyloid-β Load and White Matter Abnormalities Contribute to Hypometabolism in Alzheimer’s Dementia (2018) (15)
- Alzheimer Disease Biomarkers as Outcome Measures for Clinical Trials in MCI (2014) (14)
- AMYLOID IN DEMENTIA ASSOCIATED WITH FAMILIAL FTLD: NOT AN INNOCENT BYSTANDER (2014) (14)
- Regional Tau Effects on Prospective Cognitive Change in Cognitively Normal Older Adults (2020) (14)
- Amyloid + Activation = Alzheimer's? (2009) (14)
- Functional Imaging, the Frontal Lobes, and Dementia (1993) (13)
- Early life sets the stage for aging (2016) (13)
- Time for tau. (2014) (13)
- Imaging Interactions between Alzheimer's Disease and Cerebrovascular Disease (2002) (13)
- What are the threats to successful brain and cognitive aging? (2019) (13)
- Correction to: Relevance of biomarkers across different neurodegenerative diseases (2020) (13)
- Alzheimer's Pathology Is Associated with Dedifferentiation of Intrinsic Functional Memory Networks in Aging. (2021) (13)
- Positron and single photon emission tomography in the differential diagnosis of dementia (1990) (12)
- Single‐Photon Emission Computed Tomographic Perfusion Imaging in Autopsy‐Diagnosed Dementia (1993) (12)
- Staging tau pathology with tau PET in Alzheimer’s disease: a longitudinal study (2021) (12)
- Evaluation of a visual interpretation method for tau‐PET with 18F‐flortaucipir (2020) (12)
- Amyloid and tau PET-positive cognitively unimpaired individuals are at high risk for future cognitive decline (2022) (12)
- Altered excitatory and inhibitory neuronal subpopulation parameters are distinctly associated with tau and amyloid in Alzheimer’s disease (2022) (12)
- Enhanced cutaneous vascular response in AD subjects under donepezil therapy (2004) (12)
- Genotype status of the dopamine-related catechol-O-methyltransferase (COMT) gene corresponds with desirability of “unhealthy” foods (2015) (12)
- A semi-mechanism approach based on MRI and proteomics for prediction of conversion from mild cognitive impairment to Alzheimer’s disease (2016) (12)
- Alzheimer risk genes modulate the relationship between plasma apoE and cortical PiB binding (2015) (12)
- The Complexity of Subjective Cognitive Decline. (2017) (12)
- Age-related variability in decision-making: Insights from neurochemistry (2018) (12)
- [125I]5-iodo-6-nitroquipazine: a potent and selective ligand for the 5-hydroxytrrptamine uptake complex. II. In vivo studies in rats (1993) (11)
- Associations among locus coeruleus catecholamines, tau pathology, and memory in aging (2022) (11)
- Two Novel Mutations in the First Transmembrane Domain of Presenilin1 Cause Young-Onset Alzheimer's Disease. (2017) (11)
- Tract-Specific Correlates of Neuropsychological Deficits in Patients with Subcortical Vascular Cognitive Impairment. (2016) (11)
- Abnormal tau in amyloid PET negative individuals (2021) (10)
- The impact of PICALM genetic variations on reserve capacity of posterior cingulate in AD continuum (2016) (10)
- Amyloid imaging: liberal or conservative? Let the data decide. (2011) (10)
- The Worldwide Alzheimer's Disease Neuroimaging Initiative: ADNI‐3 updates and global perspectives (2021) (10)
- Age, vascular disease, and Alzheimer’s disease pathologies in amyloid negative elderly adults (2021) (10)
- Development of a mnemonic discrimination task using naturalistic stimuli with applications to aging and preclinical Alzheimer's disease (2019) (10)
- Method to Correlate 1 H MRSI and 18 FDG-PET (2000) (10)
- Differences in Prefrontal, Limbic, and White Matter Lesion Volumes According to Cognitive Status in Elderly Patients with First-Onset Subsyndromal Depression (2014) (10)
- Analytical and Clinical Performance of Amyloid-Beta Peptides Measurements in CSF of ADNIGO/2 Participants by an LC-MS/MS Reference Method. (2020) (10)
- Methodological and Conceptual Issues in the Study of the Aging Brain (2009) (10)
- The Centiloid Scale: Standardization of amyloid imaging measures (2013) (9)
- Tau and β-Amyloid Burden Predict Actigraphy-Measured and Self-Reported Impairment and Misperception of Human Sleep (2021) (9)
- In vivo braak staging using 18F-AV1451 Tau PET imaging (2015) (9)
- Amyloid-associated increases in soluble tau relate to tau aggregation rates and cognitive decline in early Alzheimer’s disease (2022) (9)
- A New Tool for Clinical Neuroscience-Synaptic Imaging. (2018) (9)
- FAM222A encodes a protein which accumulates in plaques in Alzheimer’s disease (2020) (9)
- Higher CSF sTNFR1-related proteins associate with better prognosis in very early Alzheimer’s disease (2021) (9)
- Apolipoprotein E, neurodegeneration, and Alzheimer disease. (2013) (8)
- An In Vivo Microdialysis Study of Striatal 6-[18F]Fluoro-L-m-Tyrosine Metabolism (1998) (8)
- Relative contributions of biomarkers in Alzheimer's disease. (2012) (8)
- A telescope GWAS analysis strategy, based on SNPs-genes-pathways ensamble and on multivariate algorithms, to characterize late onset Alzheimer’s disease (2020) (8)
- Is amnestic mild cognitive impairment always AD? (2008) (8)
- Entorhinal cortex and hippocampus in Alzheimer's disease, subcortical ischemic vascular dementia and mixed dementia (2000) (8)
- 18 F-flortaucipir PET to autopsy comparisons in Alzheimer’s disease and other neurodegenerative diseases (2020) (8)
- Synthesis and evaluation of high affinity, aryl-substituted [18F]fluoropropylbenzamides for dopamine D-2 receptor studies. (1992) (8)
- The proteomics of positron emission tomography (2004) (8)
- Contribution of Alzheimer's biomarkers and risk factors to cognitive impairment and decline across the Alzheimer's disease continuum (2021) (8)
- Amyloid imaging: Coming to a PET scanner near you (2010) (8)
- Framework : Toward a Biological Definition of Alzheimer ' s Disease (2018) (7)
- Neuroimaging in non-Alzheimer dementias (2004) (7)
- Dementia: finding the signals in the noise (2005) (7)
- Positron Tomography and the Differential Diagnosis and Pathophysiology of Alzheimer’s Disease (1985) (7)
- Reduced Repetition Suppression in Aging is Driven by Tau–Related Hyperactivity in Medial Temporal Lobe (2021) (7)
- A robust and interpretable machine learning approach using multimodal biological data to predict future pathological tau accumulation (2022) (7)
- Spatially Adaptive Varying Correlation Analysis for Multimodal Neuroimaging Data (2019) (7)
- Correlation between Alzheimer’s disease and type 2 diabetes using non-negative matrix factorization (2021) (7)
- How Will Aducanumab Approval Impact AD Research? (2021) (6)
- O1-02-06: Twelve-month cerebral metabolic declines in probable Alzheimer's disease and amnestic mild cognitive impairment: Preliminary findings from the Alzheimer's disease neuroimaging initiative (ADNI) (2008) (6)
- Imaging Tau Pathology-The Next Step. (2020) (6)
- P3-070 Adding FDG-PET to clinical history and examination improves the accuracy of dementia diagnosis (2004) (6)
- Dissociation of tau pathology and neuronal hypometabolism within the ATN framework of Alzheimer’s disease (2022) (6)
- Baseline FDG-PET and volumetric MRI predicts Alzheimer's disease conversion from mild cognitive impairment: An ADNI study (2013) (6)
- Opening a window on cerebral cholinergic function (1999) (6)
- Predicting Alzheimer’s disease progression using multi-modal deep learning approach (2019) (6)
- Uncovering the heterogeneity and temporal complexity of neurodegenerative diseases with Subtype and Stage Inference (2018) (6)
- Increasing participant diversity in AD research: Plans for digital screening, blood testing, and a community‐engaged approach in the Alzheimer's Disease Neuroimaging Initiative 4 (2022) (6)
- A Methodology for Specifying PET Volumes-of-Interest Using Multi- Modality Techniques (1997) (6)
- Evaluation of [18F]-JNJ-64326067-AAA tau PET tracer in humans. (2021) (6)
- Comprehensive analysis of epigenetic clocks reveals associations between disproportionate biological ageing and hippocampal volume (2022) (6)
- Autosomal dominant and sporadic late onset Alzheimer disease share a common in vivo pathophysiology. (2022) (6)
- Following the pathway to Alzheimer’s disease (2018) (6)
- Hippocampal Connectivity with Retrosplenial Cortex is Linked to Neocortical Tau Accumulation and Memory Function (2021) (5)
- LOSS OF FUNCTIONAL CONNECTIVITY IS GREATER OUTSIDE THE DEFAULT MODE NETWORK IN NON-FAMILIAL EARLY-ONSET AD VARIANTS (2014) (5)
- Diagnostic accuracy of FDG-PET in evaluation of dementia: International multicenter pooled brain scan and autopsy data (2000) (5)
- Amyloid and Tau PET positive cognitively unimpaired individuals: Destined to decline? (2022) (5)
- Diagnostic Accuracy of Amyloid and FDG PET in Pathologically-Confirmed Dementia (S8.005) (2014) (5)
- An IL1RL1 genetic variant lowers soluble ST2 levels and the risk effects of APOE-ε4 in female patients with Alzheimer’s disease (2022) (5)
- A peek behind the curtain: amyloid imaging, referrals, and specialist memory evaluations. (2013) (5)
- Biomarkers and brain connectivity. (2013) (5)
- The BIN1 rs744373 SNP is associated with increased tau-PET levels and impaired memory (2019) (5)
- Subcortical vascular dementia exists! (2011) (4)
- Imaging Studies of Aging, Neurodegenerative Disease, and Alcoholism (1995) (4)
- Distinct [18F]AV1451 retention patterns in clinical variants of Alzheimer’s disease (2015) (4)
- Whole Brain Atrophy and Sample Size Estimate via Iterative Principal Component Analysis for Twelve-month Alzheimer's Disease Trials (2013) (4)
- Head injury is associated with tau deposition on PET in MCI and AD patients (2021) (4)
- Cognitive functioning and dementia prevalence in older latinos: Cardiovascular and cultural correlates (2000) (4)
- P3-451 Computer-based cognitive therapy for mild cognitive impairment: Results of a pilot randomized, controlled trial (2006) (4)
- Are low levels of PiB-PET signal clinically significant? (2015) (4)
- Effect of CLU genetic variants on cerebrospinal fluid and neuroimaging markers in healthy, mild cognitive impairment and Alzheimer’s disease cohorts (2016) (4)
- Association of plasma and cortical beta-amyloid is modulated by APOE ε4 status. (2014) (4)
- Dissection of the polygenic architecture of neuronal Aβ production using a large sample of individual iPSC lines derived from Alzheimer’s disease patients (2022) (4)
- The practical utility of amyloid and FDG-PET in an academic dementia center (2013) (4)
- Crossed cerebellar diaschisis on 18F-FDG PET: Frequency across neurodegenerative syndromes and association with 11C-PIB and 18F-Flortaucipir (2021) (4)
- The changing definition of Alzheimer's disease (2021) (4)
- Dynamic PET studies of blood-brain barrier permeability in Alzheimer's disease (1985) (4)
- Quantification of amyloid beta and tau PET without a structural MRI (2022) (3)
- Glucose metabolism patterns: A potential index to characterize brain ageing and predict high conversion risk into cognitive impairment (2022) (3)
- Prospective study of cognitive function (cog fcn) in women with early-stage breast cancer (ESBC): Predictors of cognitive decline. (2013) (3)
- Tau PET with [18F]AV1451 in non-alzheimer's disease neurodegenerative syndromes (2015) (3)
- Conscientiousness is associated with less amyloid deposition in cognitively normal aging. (2020) (3)
- AV1451-PET CORTICAL UPTAKE AND REGIONAL DISTRIBUTION PREDICTS LONGITUDINAL ATROPHY IN ALZHEIMER’S DISEASE (2017) (3)
- Progression of Regional Cerebral Glucose Metabolic Abnormalities in Alzheimer's Disease (1987) (3)
- Functional brain architecture is associated with the rate of tau accumulation in Alzheimer’s disease (2020) (3)
- Is verbal episodic memory in elderly individuals with amyloid deposits preserved through altered neuronal function? (2013) (3)
- Elevated Dopamine Synthesis as a Mechanism of Cognitive Resilience in Aging. (2021) (3)
- New neuroimaging techniques for investigating of brain-behavior relationships. (1992) (3)
- Simultaneous Covariance Inference for Multimodal Integrative Analysis (2019) (3)
- Impact of apolipoprotein varepsilon4-cerebrospinal fluid beta-amyloid interaction on hippocampal volume loss over 1 year in mild cognitive impairment (2011) (3)
- Vascular Dementia: Cerebrovascular Mechanisms and Clinical Management (2005) (3)
- Comparing ATN-T designation by tau PET visual reads, tau PET quantification, and CSF PTau181 across three cohorts (2021) (3)
- Abstracts of Presentations at the International Conference on Basic and Clinical Multimodal Imaging (BaCI), a Joint Conference of the International Society for Neuroimaging in Psychiatry (ISNIP), the International Society for Functional Source Imaging (ISFSI), the International Society for Bioelectr (2013) (3)
- Challenges and Opportunities with Causal Discovery Algorithms: Application to Alzheimer’s Pathophysiology (2020) (3)
- Relevance of biomarkers across different neurodegenerative diseases (2020) (3)
- APOE effect on Alzheimer’s biomarkers in older adults with significant memory concern (2015) (3)
- Tau and β-Amyloid-The Malignant Duo. (2016) (3)
- CSF biomarker associations with change in hippocampal volume and precuneus thickness: implications for the Alzheimer’s pathological cascade (2012) (3)
- Initial Experience with [18F]AV1451 PET in AD and non-AD Tauopathies (P5.005) (2015) (3)
- Multiplex Mass Spectrometry Analysis of Amyloid Proteins in Human Plasma for Alzheimer's Disease Diagnosis. (2021) (3)
- Change in amyloid deposition is related to concurrent cognitive change in MCI (2011) (2)
- LONGITUDINAL BRAIN METABOLIC CHANGES IN FRONTOTEMPORAL LOBAR DEGENERATION CONTINUUM (2016) (2)
- AV1451-PET CORTICAL UPTAKE AND REGIONAL DISTRIBUTION PREDICT LONGITUDINAL ATROPHY IN ALZHEIMER’S DISEASE (2017) (2)
- COMBINING CSF AB42 AND PET FLORBETAPIR TO PREDICT DIAGNOSIS, TAU, ATROPHY, AND COGNITION (2014) (2)
- Self- versus informant-based cognitive complaints: Relation of E-Cog scores to imaging, biomarkers and clinical Status in ADNI-2 (2013) (2)
- PET 6-[ 18 F ] fl uoro-Lm-tyrosine studies of dopaminergic function in human and nonhuman primates (2008) (2)
- Alzheimer Disease Spectrum (2020) (2)
- LOSS OF FUNCTIONAL CONNECTIVITY IS GREATER OUTSIDE THE DEFAULT MODE NETWORK IN NON-FAMILIAL EARLY-ONSET AD VARIANTS (2014) (2)
- A β AMYLOID & GLUCOSE METABOLISM IN THREE VARIANTS OF PRIMARY PROGRESSIVE APHASIA (2009) (2)
- O1-04-04 The Alzheimer’s disease neuroimaging initiative: Progress report (2007) (2)
- Neuroimaging and the Diagnosis of Dementia (1994) (2)
- Author response: Hippocampal activation is associated with longitudinal amyloid accumulation and cognitive decline (2017) (2)
- P2-167 Patterns of cerebral hypoperfusion in Alzheimer's disease and mild cognitive impairment measured with arterial spin labeled MRI (2004) (2)
- Hippocampal connectivity with retrosplenial cortex drives neocortical tau accumulation and memory function (2021) (2)
- CLINICALLY DIAGNOSED PROBABLE AD CASES WITH A NEGATIVE AMYLOID PET SCAN: CLINICAL FINDINGS (2014) (2)
- Influence of rare reelin variants on quantitative PET imaging and CSF phenotypes in late-onset Alzheimer’s disease (2015) (2)
- Youthfulness begins in youth (2021) (2)
- Atrophy , hypometabolism and clinical trajectories in amyloid negative probable AD patients (2018) (2)
- CENTILOID THRESHOLDS FOR AMYLOID POSITIVITY DERIVED FROM AUTOPSY-PROVEN CASES (2016) (2)
- Region-specific associations of brain glucose metabolism with age and beta-amyloid deposition in normal aging (2013) (2)
- Tracking brain amyloid-β in presymptomatic Alzheimer's disease (2012) (2)
- A Double-Edged Sword: The Role of Prior Knowledge in Memory Aging (2022) (2)
- Beta-amyloid deposition in the human brain disrupts nrem slow wave sleep and associated hippocampus-dependent long-term memory (2015) (2)
- High-performing older adults: Cognitive and brain correlates (2013) (2)
- EXPLAINING [18F]-AV-1451 VARIABILITY IN HEALTHY CONTROLS ACROSS THE LIFESPAN (2018) (2)
- Will Neuroimaging help us understand Alzheimer's disease? (2009) (2)
- Fusiform Gyrus Phospho‐Tau is Associated with Failure of Proper Name Retrieval in Aging (2021) (2)
- CLINICALLY DIAGNOSED PROBABLE AD CASES WITH A NEGATIVE AMYLOID PET SCAN: CLINICAL FINDINGS (2014) (2)
- Dad Can Do Time Travel … But Grandpa Can't! (2014) (2)
- The 1998 Workshop on Neuroimaging Research in Alzheimer's Disease: Observation and issues (2000) (2)
- U.S. POINTER Imaging: Study design and launch (2020) (2)
- MODELING LONGITUDINAL FLORBETAPIR CHANGE ACROSS THE DISEASE SPECTRUM (2014) (2)
- TAU-PET PATTERNS OVERLAP AND EXCEED HYPOMETABOLISM IN ALZHEIMER'S DISEASE (2016) (2)
- Scan-Time Corrections for 80–100-min Standardizetd Uptake Volume Ratios to Measure the 18F-AV-1451 Tracer for Tau Imaging (2019) (2)
- Sleep disturbance is associated with longitudinal Aβ accumulation in healthy older adults (2020) (1)
- 195. Increased Dopamine Synthesis Capacity in Gambling Addiction Predicts Drug-Induced Enhances in Reward Learning (2017) (1)
- Author Correction: Spread of pathological tau proteins through communicating neurons in human Alzheimer’s disease (2021) (1)
- Molecular neuroimaging in Alzheimer’s disease (2004) (1)
- CSF biomarker and PIB-PET—derived beta-amyloid signature predicts Brain metabolism, grey matter and cognitive changes in non-demented subjects (2011) (1)
- Cognitive decline in healthy elderly is related to temporal lobe tau but not to cortical β-amyloid: An 18F-AV1451 and 11C-PiB PET study (2015) (1)
- Injury and Disease Linkages Effects of traumatic brain injury and posttraumatic stress disorder on Alzheimer's disease in veterans, using the Alzheimer's Disease Neuroimaging Initiative * (2014) (1)
- PARTIAL VOLUME EFFECTS AND MEDIAL TEMPORAL LOBE TAU QUANTITATION WITH PET (2017) (1)
- Neuronal injury biomarkers and prognosis in ADNI subjects with normal cognition (2014) (1)
- Evaluation of 18F‐JNJ‐067 as a tau tracer (2020) (1)
- LONGITUDINAL AMYLOID, NEURODEGENERATION AND COGNITION IN PRE-DEMENTIA ELDERLY INDIVIDUALS WITH DIFFERENT ATN PROFILES (2019) (1)
- TWO-YEAR LONGITUDINAL CHANGE IN AMYLOID DEPOSITION, GLUCOSE METABOLISM, AND HIPPOCAMPAL ATROPHY IN ADNI-2 PARTICIPANTS: RELATION TO GENETIC RISK (2014) (1)
- Introduction: Still More Questions than Answers (2009) (1)
- Reduced [ 18 F]flortaucipir retention in white matter hyperintensities compared to normal‐appearing white matter: Neuroimaging / Optimal neuroimaging measures for tracking disease progression (2020) (1)
- Discrepant diagnostic classification with AV45-PET and FDG-PET of clinically diagnosed Alzheimer's patients in the Alzheimer's Disease Neuroimaging Initiative (2012) (1)
- Integrating events in the disintegration of Alzheimer's disease. (2021) (1)
- Biomarker predictors of cognitive decline in healthy older participants in the Alzheimer's Disease Neuroimaging Initiative (2010) (1)
- EFFECT OF APOE4 ON THE BRAIN STRUCTURE OF HEALTHY CHILDREN: STABLE FINDINGS ACROSS METHODS (2014) (1)
- EVALUATION OF VISUAL INTERPRETATION METHODS FOR TAU PET IMAGING (2018) (1)
- Optimizing quantification of MK6240 tau PET in unimpaired older adults (2022) (1)
- Medial temporal lobe hyperactivity during memory processing in older adults is associated with entorhinal tau deposition (2020) (1)
- P3-065 FDG-PET improves differential diagnosis of dementia when clinical history and examination are ambiguous (2004) (1)
- IMPROVING THE POWER TO TRACK FIBRILLAR AMYLOID PET MEASUREMENTS AND EVALUATE AMYLOID-MODIFYING TREATMENTS USING A CEREBRAL WHITE MATTER REFERENCE REGION-OF-INTEREST (2014) (1)
- Alzheimer's disease biomarkers as outcome measures for clinical trials (2013) (1)
- Amyloid negativity in clinically diagnosed ADNI Alzheimer's disease and MCI patients (2015) (1)
- Predicting future regional tau accumulation in asymptomatic and early Alzheimer’s disease (2020) (1)
- A 3D navigational environment for specifying positron emission tomography volumes-of-interest (1995) (1)
- Novel CYP1B1-RMDN2 Alzheimers disease locus identified by genome-wide association analysis of cerebral tau deposition on PET (2023) (1)
- The ratio of holotranscobalamin to total B12 is associated with cognitive impairment in elderly Latinos with elevated depression scores (2007) (1)
- MODELING AMYLOID, TAU, AND NEURODEGENERATION ACROSS THE ALZHEIMER’S DISEASE SPECTRUM: CROSS-SECTIONAL STUDY (2018) (1)
- Relationships between cognitive activity, Alzheimer's disease pathological biomarkers and cognitive functioning in normal older adults (2013) (1)
- CEREBRAL BLOOD FLOW AND METABOLISM IN DEMENTIA: REGIONAL PATTERNS AND THE BIOLOGY OF ALZHEIMER'S DISEASE (1994) (1)
- P2-185 Metabolic and cognitive changes with computer based cognitive therapy for MCI (2006) (1)
- THE ROLE OF β-AMYLOID IN SUPERAGERS WITH SUPERIOR MEMORY PERFORMANCE AND PRESERVED BRAIN MORPHOMETRY (2017) (1)
- O2-06-05 Homocysteine and incidence of dementia and cognitive impairment in older Mexican Americans: Results from the sacramento area latino study on aging (2006) (1)
- Self-reported versus informant-based cognitive complaints: Relation of E-Cog scores to imaging biomarkers and clinical status in ADNI-2 (2013) (1)
- Temporoparietal cortical thickness outperforms hippocampal volume as a biomarker for atypical and early-onset Alzheimer's disease (2013) (1)
- Evaluation of the associations between [11C]PIB and [18F]AV1451 PET retention and MRI atrophy in Alzheimer’s Disease (2016) (1)
- P4-039 Clinical and MRI factors for vascular dementia in the cardiovascular health study cognition study (2004) (1)
- Subclinical epileptiform activity in Alzheimer's disease (2012) (1)
- VASCULAR RISK FACTORS IMPACT COGNITION INDEPENDENT OF PIB PET AND MRI MEASURES OF AD AND VASCULAR BRAIN INJURY (2014) (1)
- P-024 The pattern and severity of FDG pet abnormalities in Alzheimer’s disease and amnestic mild cognitive impairment: Preliminary findings from the Alzheimer’s disease neuroimaging initiative (2007) (1)
- P1-258: Pinpointing change in Alzheimer's disease: Longitudinal FDG-PET analyses from the Alzheimer's disease neuroimaging initiative (2008) (1)
- Prospective study of cognitive function (cog fcn) in women with early-stage breast cancer (BC): Relationship between perceived and measurable cognitive deficits. (2013) (1)
- Glucose metabolism reflects local atrophy and tau pathology in symptomatic Alzheimers disease (2021) (1)
- MODELING AMYLOID, TAU, AND NEURODEGENERATION ACROSS THE ALZHEIMER’S DISEASE SPECTRUM: CROSS-SECTIONAL STUDY (2018) (1)
- Cerebrospinal Fluid Biomarkers and [11C]Pittsburgh Compound-B PET Concordance in Alzheimer Disease vs. Frontotemporal Dementia Syndromes (P1.213) (2015) (1)
- LIFETIME COGNITIVE ACTIVITY, APOLIPOPROTEIN E GENOTYPE, AND BRAIN BETA-AMYLOID (2014) (1)
- Coronary risk correlates with cerebral amyloid deposition in non demented elders (2011) (1)
- An accurate and computationally efficient method for voxel-by-voxel estimation of the Pittsburgh compound B distribution volume ratio (2008) (1)
- Abnormal neural oscillations depicting excitatory‐inhibitory imbalance are distinctly associated with amyloid and tau depositions in Alzheimer's disease (2021) (1)
- P4-038 Classification of vascular dementia in the cardiovascular health study cognition study (2004) (1)
- EXISTING THRESHOLDS FOR PIB POSITIVITY ARE TOO HIGH (2014) (1)
- Examining relations of age and beta-amyloid with tau deposition measured using 18F-AV-1451 in cognitively normal older adults (2015) (1)
- DIAGNOSTIC ACCURACY OF AMYLOID- VERSUS FDG-PET IN AUTOPSY-CONFIRMED DEMENTIA (2016) (1)
- Accuracy of different biomarkers to predict progression from mild cognitive impairment to probable Alzheimer's dementia in two independent clinical series (2012) (1)
- TAU-PET PATTERNS OVERLAP AND EXCEED HYPOMETABOLISM IN ALZHEIMER'S DISEASE (2016) (1)
- Reduced amyloid deposition and greater hypometabolism in people with Alzheimer's disease who are APOE-ε4–positive (2013) (1)
- Heritability of regional brain volumes in large-scale neuroimaging and genetic studies (2017) (1)
- Associations of [18F]AV1451 Tau PET with age, ApoE genotype, and cognition in Alzheimer’s disease (2015) (1)
- Distinct Factors Drive the Spatiotemporal Progression of Tau Pathology in Older Adults (2021) (1)
- Structural and functional brain imaging and dementia diagnosis (2000) (1)
- Neuroimaging and Pathological Correlates of Dementia Associated with Subcortical Ischemic Vascular Disease (SIVD) (2001) (1)
- SAMPLE SIZES FOR 24-MONTH ALZHEIMER’S PREVENTION TRIALS USING BIOMARKER ENDPOINTS IN COGNITIVELY UNIMPAIRED AMYLOID-POSITIVE ADULTS (2017) (0)
- P3-173: Verbal list learning in cases with Alzheimer's disease, vascular, and mixed neuropathology (2008) (0)
- TAU PATHOLOGY AND GRAY MATTER ATROPHY CONTRIBUTE TO COGNITIVE IMPAIRMENT IN ALZHEIMER’S DISEASE (2017) (0)
- Evaluation of 18 F‐JNJ‐067 as a tau tracer: Neuroimaging / New imaging methods (2020) (0)
- Amyloid pathway-based candidate gene analysis of [11C]PiB-PET in the Alzheimer’s Disease Neuroimaging Initiative (ADNI) cohort (2011) (0)
- P3-094 Predicting cognitive decline with baseline hippocampal volume and rate of hippocampal atrophy (2004) (0)
- Book Review (2003) (0)
- P3-172 Gene-infection interaction and risk of dementia (2006) (0)
- The trend of disruption in the functional brain network topology of Alzheimer’s disease (2021) (0)
- PATIENT-TAILORED PREDICTIONS OF GRAY MATTER ATROPHY IN ALZHEIMER’S DISEASE BASED ON BASELINE FLORTAUCIPIR AND CONNECTOME-BASED SPREAD (2018) (0)
- CSF p‐Tau/AΒ40 ratio adjusts for the variance of CSF production and predicts brain tau accumulation in Alzheimer’s disease (2020) (0)
- Metacognitive monitoring abilities and amyloid deposition imaging in normal elderly individuals (2009) (0)
- IC-P2-098: Frequency of hemispheric metabolic asymmetry in probable Alzheimer's disease (2008) (0)
- EFFECTS OF BASELINE REGIONAL AMYLOID DEPOSITION PATTERNS ON SUBSEQUENT ACCUMULATION (2016) (0)
- Relationship Between Regional Brain Amyloid-β Deposition and Brain Atrophy Rates in Mild Cognitive Impairment (2010) (0)
- Reply (2006) (0)
- [ 18 F]FLORTAUCIPIR PET AND PATHOLOGY CORRELATIONS IN ALZHEIMER’S DISEASE, NON-ALZHEIMER’S TAUOPATHIES, AND OTHER NEURODEGENERATIVE DISEASES (2019) (0)
- Association between the Alzheimer's disease–related hypometabolic convergence index and clinical ratings in cognitively normal older adults with and without significant fibrillar amyloid burden: Findings from the Alzheimer's Disease Neuroimaging Initiative (2013) (0)
- [P4–196]: WITHDRAWN (2017) (0)
- Diverging PiB and FDG covariance patterns across clinical variants of Alzheimer's disease (2012) (0)
- Increased Serotonin Synthesis Capacity is Associated with Longitudinal Cortical Atrophy and Worsening Depressive Symptoms (2022) (0)
- NEURODEGENERATIVE AND COGNITIVE PROFILE OF PATIENTS WITH A TYPICAL PHENOTYPE OF AD BUT WITH A NEGATIVE AMYLOID SCAN (2014) (0)
- Crossed cerebellar diaschisis on 18F-FDG PET across neurodegenerative diseases: frequency and association with 11C-PIB and 18F-FTP (2020) (0)
- MEDIAL TEMPORAL LOBE TAU IS STRONGLY RELATED TO EPISODIC MEMORY DECLINE IN AGING (2017) (0)
- The pattern of cerebral hypometabolism and its association with clinical ratings in cognitively normal older adults with and without significant fibrillar amyloid burden: Findings from the Alzheimer's Disease Neuroimaging Initiative (2013) (0)
- Hippocampal‐retrosplenial connectivity is associated with tau pathology and memory in cognitively normal older adults (2020) (0)
- Diagnostic Accuracy of Amyloid versus FDG PET in Patients with Cognitive Impairment and Autopsy (2019) (0)
- Cerebral Glucose Metabolism and Memory in Aged RhesusMacaques (1996) (0)
- Diverging PIB and FDG covariance patterns across clinical variants of Alzheimer's disease (2012) (0)
- HOW AD-SPECIFIC ARE AB AND TAU IMAGING BIOMARKERS? (2016) (0)
- HEAD-TO-HEAD COMPARISON OF PIB AND FDG-PET IN AUTOPSY-CONFIRMED CASES (2018) (0)
- APOE e4 status modulates the association of plasma and cortical Aβ: Relation of plasma Aβ and [11C]PiB PET in the ADNI cohort (2011) (0)
- HEAD-TO-HEAD COMPARISON OF PIB AND FDG-PET IN AUTOPSY-CONFIRMED CASES (2018) (0)
- EFFECTS OF TAU AND AMYLOID DEPOSITION MEASURED BY PET ON DOMAIN-SPECIFIC MEMORY FUNCTION IN OLD AGE (2018) (0)
- Multimodal genome‐wide meta‐analysis of brain amyloidosis reveals heterogeneity across CSF, PET, and pathological amyloid measures (2020) (0)
- CURRENT COGNITIVE ENGAGEMENT IS ASSOCIATED WITH REDUCED GLUCOSE HYPOMETABOLISM IN COGNITIVELY NORMAL ELDERLY (2016) (0)
- INDIVIDUAL-BASED NETWORK ANALYSIS: A NOVEL APPROACH TO INVESTIGATE THE PATHOLOGICAL SPREAD OF PHF TAU USING GRAPH THEORY IN CLINICAL AND PRECLINICAL STAGES OF ALZHEIMER’S DISEASE (2019) (0)
- Oral Sessions: O3-03: Biomarkers: Temporal Sequence of Biomarkers (2013) (0)
- Cross‐sectional amyloid and tau PET in cognitively normal older adults enrolled in the U.S. POINTER lifestyle intervention trial (2021) (0)
- Title Spontaneous eye blink rate and dopamine synthesis capacity : preliminary evidence for an absence of positive correlation Permalink (2018) (0)
- Following the pathway to Alzheimer’s disease (2018) (0)
- RELATIONSHIP BETWEEN [18F]AV-1451 BINDING AND ANTECEDENT AMYLOID DEPOSITION, GLUCOSE HYPOMETABOLISM AND ATROPHY MEASURES: PRELIMINARY ANALYSIS IN THE ADNI COHORT (2016) (0)
- AMYLOID PET HAS GREATER CLINICAL IMPACT THAN FDG PET IN THE DIFFERENTIAL DIAGNOSIS OF AD AND FTD (2014) (0)
- Longitudinal Trajectories of Memory Performance in Patients with Early-Stage Breast Cancer (2022) (0)
- Tau and amyloid neuroimaging of ad phenotypes (2015) (0)
- NEURODEGENERATIVE AND COGNITIVE PROFILE OF PATIENTS WITH A TYPICAL PHENOTYPE OF AD BUT WITH A NEGATIVE AMYLOID SCAN (2014) (0)
- DOES APOE-ε4 HAVE AN Aβ-INDEPENDENT EFFECT ON TAU PATHOLOGY? NEUROIMAGING INVESTIGATIONS IN COGNITIVELY NORMAL ELDERS AND PATIENTS WITH ALZHEIMER’S DISEASE (2017) (0)
- An empirical measure of resilience explains individual differences in the effect of tau pathology on memory change in aging (2023) (0)
- Comparison of Amyloid PET and CSF Biomarkers in the Evaluation of Dementia (PD1.004) (2012) (0)
- The impact of beta-amyloid deposition and vascular risk factors on cortical thickness and cognition (2013) (0)
- Spectral signatures associated with cognitive aging, APOE4, amyloid‐β and measures of axonal integrity in cognitively unimpaired adults (2022) (0)
- Reaching a Diagnosis of a Dementia Subtype (2008) (0)
- EXAMINING AMYLOID AND TAU INTER-REGIONAL PET ASSOCIATION PATTERNS IN COGNITIVELY NORMAL OLDER ADULTS (2016) (0)
- Amyloid and cerebrovascular disease both contribute to cognitive impairment in individuals with high vascular risk (2010) (0)
- New Clues in Predicting Alzheimer's Disease (2009) (0)
- RELATIONSHIPS BETWEEN MEAN CORTICAL AMYLOID BURDEN AND REGIONAL GRAY MATTER REDUCTIONS IN ALZHEIMER’S DEMENTIA, MILD COGNITIVE IMPAIRMENT AND UNIMPAIRED OLDER ADULTS (2018) (0)
- Evaluation of PVC methods on head‐to‐head FTP and MK6240 (2022) (0)
- RELATIONSHIPS BETWEEN MEAN CORTICAL AMYLOID BURDEN AND REGIONAL GRAY MATTER REDUCTIONS IN ALZHEIMER’S DEMENTIA, MILD COGNITIVE IMPAIRMENT AND UNIMPAIRED OLDER ADULTS (2018) (0)
- FLORTAUCIPIR PAIRED HELICAL FILAMENT TAU BURDEN AND CORRELATION WITH COGNITIVE DECLINE IN MCI PATIENTS WITHOUT ANY Aβ (2018) (0)
- PredictingReductionofCerebrospinalFluidβ-Amyloid42 inCognitivelyHealthyControls (2015) (0)
- Progressive memory loss with low amyloid burden in former professional American football players (2013) (0)
- DOES APOE-ε4 HAVE AN Aβ-INDEPENDENT EFFECT ON TAU PATHOLOGY? NEUROIMAGING INVESTIGATIONS IN COGNITIVELY NORMAL ELDERS AND PATIENTS WITH ALZHEIMER’S DISEASE (2017) (0)
- FLORTAUCIPIR PAIRED HELICAL FILAMENT TAU BURDEN AND CORRELATION WITH COGNITIVE DECLINE IN MCI PATIENTS WITHOUT Aβ (2018) (0)
- CAVEATS WHEN SUBTRACTING TWO SERIAL MEASUREMENTS TO ESTIMATE THE NUMBER OF PARTICIPANTS NEEDED FOR CLINICAL TRIALS THAT ARE LONGER OR SHORTER THAN THE OBSERVED MEASUREMENT INTERVAL (2017) (0)
- IC-P-145 NON-AMNESTIC PHENOTYPES OF ALZHEIMER’S DISEASE, EARLYAGE OF ONSETAND APOE GENOTYPE ARE ASSOCIATED WITH TAU, NOT A b -PET (2018) (0)
- P1-267: Metabolic evidence of compensation for amyloid pathology in nondemented elderly individuals (2008) (0)
- P1-280: Amyloid and glucose metabolism in early versus late-onset Alzheimer's disease: A comparative [11C]PIBand [18F]FDG PET study (2008) (0)
- Amyloid Imaging in AD , MCI , DLB , PDD , PD , and FTD using 11 CPIB PET (0)
- NEXT-GENERATION SEQUENCING OF THE BCHE LOCUS IDENTIFIES A FUNCTIONAL SNP ASSOCIATED WITH ALZHEIMER'S DISEASE BIOMARKERS AND AGE OF ONSET (2014) (0)
- MEDIAL TEMPORAL LOBE TAU IS STRONGLY RELATED TO EPISODIC MEMORY DECLINE IN AGING (2017) (0)
- Longitudinal relationships among biomarkers in Alzheimer's disease: Findings from the Alzheimer's Disease Neuroimaging Initiative (ADNI) (2012) (0)
- Imaging the evolution and pathophysiology of Alzheimer disease (2018) (0)
- SIGNAL COHERENCE IN THE HIPPOCAMPUS IS RELATED TO ITS FUNCTIONAL ISOLATION, PRECLINICAL ALZHEIMER’S DISEASE PATHOLOGY AND MEMORY IN AGING (2019) (0)
- omers can disrupt normal neuronal homeostasis by triggering focal accumulation of axonal tau, loss of the polarized distribution of tau and dysregulation of fast axonal transport (2017) (0)
- Capitalizing on complementary FDG-PET and florbetapir-PET data sets to distinguish between early and late mild cognitive impairment using multimodal partial least squares (2012) (0)
- Spread of pathological tau proteins through communicating neurons in human Alzheimer’s disease (2020) (0)
- O1-02-02 White matter lesions are associated with cortical atrophy more than entorhinal and hippocampal atrophy (2004) (0)
- Deep learning-based polygenic risk analysis for Alzheimer’s disease prediction (2023) (0)
- Effect of beta‐amyloid and tau pathology on neural network segregation and episodic memory in aging (2020) (0)
- INCREASED AMYLOID DEPOSITION IN OLDER ADULTS AT RISK FOR PROGRESSION TO ALZHEIMER'S DISEASE DUE TO GENETIC BACKGROUND AND/OR THE PRESENCE OF SIGNIFICANT MEMORY CONCERNS (2014) (0)
- Review Articles The Alzheimer's Disease Neuroimaging Initiative: Progress report and future plans (2010) (0)
- COMPARING ATROPHY PATTERNS IN EARLY CLINICAL STAGES ACROSS DISTINCT PHENOTYPES OF ALZHEIMER'S DISEASE (2014) (0)
- PET and MR imaging in dementia prediction and diagnosis (2005) (0)
- LOWER FRONTAL AMYLOID BURDEN IN ANTIDEPRESSANT USERS: PRELIMINARY FINDINGS FROM PERSONS WITH AND WITHOUT POST-TRAUMATIC STRESS DISORDER IN THE ADNI DOD STUDY (2016) (0)
- The regional and local relationships between amyloid and MRI‐visible perivascular spaces in white matter differ according to amyloid load: An ADNI study (2020) (0)
- NORMAL COGNITION DESPITE VERY HIGH RISK FOR ALZHEIMER’S DISEASE: NEUROIMAGING AND NEUROPSYCHOLOGICAL INSIGHTS INTO RESILIENT BRAIN AGING (2016) (0)
- Predicting the Pathology of Corticobasal Syndrome Using Modified Clinical Criteria, MRI and FDG PET (P06.047) (2013) (0)
- ImpactoftheAlzheimer'sDiseaseNeuroimagingInitiative,2004to2014 (2015) (0)
- Sequential pathway inference for multimodal neuroimaging analysis (2021) (0)
- Author Correction: Multimodal hippocampal subfield grading for Alzheimer’s disease classification (2020) (0)
- P2-037: Categorical and correlational analyses of baseline fluorodeoxyglucose positron emission tomography images from the Alzheimer's disease neuroimaging initiative (2008) (0)
- RESISTANCE TO AD OVER THE LIFECOURSE (2018) (0)
- AMYLOID-β SPREADS FROM MULTIPLE EPICENTERS IN PRECLINICAL ALZHEIMER’S DISEASE (2016) (0)
- EFFECTS OF TAU AND AMYLOID DEPOSITION MEASURED BY PET ON DOMAIN-SPECIFIC MEMORY FUNCTION IN OLD AGE (2018) (0)
- S258. Dorsal, but Not Ventral Striatal Dopamine Mediates the Effect of Gambling Disorder on Compulsivity During Reversal Learning (2018) (0)
- COMPARING ATROPHY PATTERNS IN EARLY CLINICAL STAGES ACROSS DISTINCT PHENOTYPES OF ALZHEIMER'S DISEASE (2014) (0)
- NON-AMNESTIC PHENOTYPES OF ALZHEIMER’S DISEASE, EARLY AGE OF ONSET AND APOE GENOTYPE ARE ASSOCIATED WITH TAU-, NOT Aβ-PET (2018) (0)
- Imaging of vascular disease in dementia (2005) (0)
- Is Neurodegeneration Caused by A-beta? (2014) (0)
- Subjective social status, objective socioeconomic status, and memory aging (2021) (0)
- Association of cerebral microhemorrhages with amyloid deposition and hyperlipidemia (2015) (0)
- Title Large-scale genomics unveil polygenic architecture of human cortical surface area Permalink (2015) (0)
- EMERGING AMYLOID PATHOLOGY (2017) (0)
- Apolipoprotein E ɛ4–related effects on cognition are limited to the Alzheimer’s disease spectrum (2021) (0)
- P2-279 Does type 2 diabetes attenuate cortisol variability in demented Mexican Americans? (2004) (0)
- IC-P2-128: Twelve-month cerebral metabolic declines in probable Alzheimer's disease and amnestic mild cognitive impairment: Preliminary findings from the Alzheimer's disease neuroimaging initiative (2008) (0)
- EFFECTS OF AMYLOID STATUS AND AGE ON LONGITUDINAL REGIONAL BRAIN ATROPHY IN ELDERLY HEALTHY CONTROLS (2014) (0)
- Relationship between cognition and tau protein deposition measured by PET in subjects with normal cognition and within the Alzheimer’s disease spectrum: A meta‐analysis and systematic review (2021) (0)
- COMPARING LIBERAL AND CONSERVATIVE THRESHOLDS FOR AMYLOID PET POSITIVITY IN AUTOPSY-PROVEN CASES (2014) (0)
- CHAPTER 6 – Autoradiography as a Tool for PET/SPECT Tracer Selection and Assessment (1996) (0)
- PATIENT-TAILORED PREDICTIONS OF GRAY MATTER ATROPHY IN ALZHEIMER’S DISEASE BASED ON BASELINE FLORTAUCIPIR AND CONNECTOME-BASED SPREAD (2018) (0)
- [18F]FLORTAUCIPIR PET AND PATHOLOGY CORRELATIONS IN ALZHEIMER’S DISEASE, NON-ALZHEIMER’S TAUOPATHIES, AND OTHER NEURODEGENERATIVE DISEASES (2019) (0)
- Cerebral metabolism in Alzheimer's disease (1989) (0)
- Author Correction: Multimodal hippocampal subfield grading for Alzheimer’s disease classification (2020) (0)
- Longitudinal tau accumulation in cognitively normal older adults is associated with baseline age, pathology, and activation (2021) (0)
- Tau spreads through episodic memory networks in the aging brain (2020) (0)
- 2018 NIA-AA Research Framework to Investigate the Alzheimer ’ s Disease Continuum 1 2 DRAFT 7-18-17 3 4 5 Clifford (2017) (0)
- PET, MRI and memory function in a community sample: The Salsa study (2000) (0)
- Characteristic patterns of inter- and intra-hemispheric metabolic connectivity in patients with stable and progressive mild cognitive impairment and Alzheimer’s disease (2018) (0)
- Reduced amyloid deposition and greater hypometabolism in APOE-ε4-positive Alzheimer’s disease patients (2013) (0)
- Age-related variability in decision-making: Insights from neurochemistry (2018) (0)
- Dr. Koss and Associates Reply (2006) (0)
- Data from: Longitudinal structural and metabolic changes in frontotemporal dementia (2021) (0)
- Association of cerebral microhemorrhages with amyloid deposition and hyperlipidemia (2015) (0)
- The role of APOE genotype in early mild cognitive impairment (E-MCI): Preliminary results from ADNI-2 (2012) (0)
- NON-AMNESTIC PHENOTYPES OF ALZHEIMER’S DISEASE, EARLY AGE OF ONSET AND APOE GENOTYPE ARE ASSOCIATED WITH TAU, NOT Aβ-PET (2018) (0)
- CENTILOID THRESHOLDS FOR AMYLOID POSITIVITY DERIVED FROM AUTOPSY-PROVEN CASES (2016) (0)
- Pattern Discovery in Brain Imaging Genetics via SCCA Modeling with a Generic Non-convex Penalty (2017) (0)
- Improved factor analysis of dynamic PET images to estimate arterial input function and tissue curves (2015) (0)
- DISCREPANCIES IN TAU AND β-AMYLOID BURDEN ARE FREQUENT ACROSS THE SPECTRUM OF NORMAL AGING AND ALZHEIMER’S DISEASE (2018) (0)
- Cascaded Multi-view Canonical Correlation (CaMCCo) for Early Diagnosis of Alzheimer’s Disease via Fusion of Clinical, Imaging and Omic Features (2017) (0)
- Apoe4 Lipoprotein 4 Reduces Risk of Dementia from High Sensitivity C-Reactive Protein (2006) (0)
- Pathological tau in cognitively normal older adults predicts prospective neurodegeneration and cognitive decline (2022) (0)
- Neuroimaging Discoveries of Protein and Circuit Convergence in Aging and Disease (2015) (0)
- Basic principles of FDG PET (2005) (0)
- The effect of age and amyloid status on hippocampal atrophy rate in normal controls and people with mild cognitive impairment in the ADNI cohort (2013) (0)
- R-clustering technique for initialization of factor analysis of dynamic PET images (2015) (0)
- P1-312: Differentiating amnestic mild cognitive impairment converting to probable Alzheimer's disease from stable amnestic mild cognitive impairment using FDG-PET and an Alzheimer's disease-related hypometabolism overlap index (2008) (0)
- BIOLOGICAL CONSEQUENCES OF SUBTHRESHOLD AMYLOID ACCUMULATION (2019) (0)
- Tau PET as a prognostic marker in preclinical and prodromal Alzheimer’s disease (2021) (0)
- EFFECTS OF TAU DEPOSITION ON CEREBRAL GLUCOSE METABOLISM IN NORMAL OLDER ADULTS VARY BY AMYLOID LEVEL (2017) (0)
- IC-P2-114: Meta-analysis ROIs and minimal deformation templates improve PET-FDG as a candidate biomarker in Alzheimer's disease (2008) (0)
- Colocalization of atrophy and tau improves AI classification of Alzheimer phenotypical variants (2020) (0)
- Utility of amyloid PET in the differential diagnosis of dementia: An autopsy-confirmed series (2013) (0)
- Amyloid imaging in the multimodal evaluation of MCI (2012) (0)
- SPATIAL PATTERNS OF TAU DEPOSITION IN AGING (2019) (0)
- CURRENT COGNITIVE ENGAGEMENT IS ASSOCIATED WITH REDUCED GLUCOSE HYPOMETABOLISM IN COGNITIVELY NORMAL ELDERLY (2016) (0)
- Regression-to-pons normalization of FDG-PET improves discrimination of Alzheimer's disease from healthy aging (2010) (0)
- Regional Amyloid-β Load and White Matter Abnormalities Contribute to Hypometabolism in Alzheimer’s Dementia (2018) (0)
- Beta-amyloid deposition in normal elderly is related to longitudinal but not cross-sectional cognitive decline (2012) (0)
- AMYLOID PET HAS GREATER CLINICAL IMPACT THAN FDG PET IN THE DIFFERENTIAL DIAGNOSIS OF AD AND FTD (2014) (0)
- LOCAL SLOW WAVE MEASURES DURING NREM SLOW WAVE SLEEP ACCURATELY TRACK β-AMYLOID STATUS (2019) (0)
- P3‐013: Withdrawn (2015) (0)
- Longitudinal tau accumulation interacts with cortical thinning to predict steeper memory decline in cognitively normal older adults (2022) (0)
- HUMAN IN VIVO TAU PATHOLOGY, IMPAIRED NREM SLEEP OSCILLATIONS AND MEMORY DECLINE IN AGING (2018) (0)
- Glucose metabolism mainly reflects local atrophy and tau pathology at symptomatic stages of Alzheimer’s disease (2020) (0)
- LONGITUDINAL BRAIN METABOLIC CHANGES IN FRONTOTEMPORAL LOBAR DEGENERATION CONTINUUM (2016) (0)
- AN NREM SLEEP SIGNATURE OF HUMAN IN VIVO TAU BURDEN (2016) (0)
- The role of APOE-ɛ4 genotype in early mild cognitive impairment (EMCI): Preliminary results from ADNI-2 (2012) (0)
- Temporoparietal cortical thickness outperforms hippocampal volume as a biomarker for atypical and early-onset Alzheimer's disease (2013) (0)
- Evaluation of PVC methods on head‐to‐head FTP and MK6240 (2022) (0)
- How ‘atypical’ is the neuroimaging signature of Alzheimer’s atypical variants? MRI and PET imaging of posterior cortical atrophy and logopenic variant of primary progressive aphasia (2020) (0)
- COMPARING THE DIAGNOSTIC ACCURACIES OF CSF Aβ42 AND PET FLORBETAPIR (2014) (0)
- AV1451-PET UPTAKE AND CSF BIOMARKERS IN A HETEROGENEOUS CLINICAL SAMPLE: TWO SIDES OF THE SAME COIN? (2017) (0)
- Topographic extent of cerebral hypometabolism predicts time of conversion from aMCI to Alzheimer's disease: Data from the Alzheimer's Disease Neuroimaging Initiative (2010) (0)
- Impact of off‐target signal on longitudinal FTP quantification (2022) (0)
- CORTICAL TAU DEPOSITION FOLLOWS PATTERNS OF ENTORHINAL FUNCTIONAL CONNECTIVITY IN COGNITIVELY NORMAL OLDER ADULTS (2019) (0)
- DISTINCT NEURAL OSCILLATION ABNORMALITIES ASSOCIATED WITH AMYLOID-BETA AND TAU IN ALZHEIMER’S DISEASE (2018) (0)
- P2-209 Regional specificity of brain in metabolite changes in ad (2004) (0)
- How will amyloid imaging really be used inside and outside clinical trials? (2011) (0)
- F-18-AV-1451 in frontotemporal dementia spectrum disorders (2016) (0)
- Predicting future regional tau accumulation in preclinical Alzheimerâ•Žs disease: Neuroimaging: Understanding tau progression (2020) (0)
- Predicting future regional tau accumulation in preclinical Alzheimer’s disease (2020) (0)
- AMYLOID ACCUMULATION WITHIN THE NEGATIVE RANGE IS LINKED TO MEMORY DECLINE IN COGNITIVELY NORMAL OLDER INDIVIDUALS (2017) (0)
- Earliest accumulation of β-amyloid occurs within the default-mode network and concurrently affects brain connectivity (2017) (0)
- Supplementary Appendix of “Simultaneous Covariance Inference for Multimodal Integrative Analysis” (2019) (0)
- IC-P-114 Improved classification of MCI and Alzheimer’s disease using diffusion tensor imaging of cingulum white matter (2006) (0)
- P1-222 ApoE4 lipoprotein 4 reduces risk of dementia from high sensitivity C-reactive protein (2006) (0)
- Title Increased Striatal Dopamine Synthesis Capacity in Gambling Addiction Permalink (2018) (0)
- NREM sleep as a novel protective cognitive reserve factor in the face of Alzheimer's disease pathology (2023) (0)
- SSRI USE ASSOCIATED WITH REDUCED AMYLOID BURDEN IN PERSONS WITH COMBAT-RELATED PTSD: PRELIMINARY FINDINGS FROM ADNI-DOD (2017) (0)
- 18F-flortaucipir (AV-1451) tau PET in frontotemporal dementia syndromes (2019) (0)
- Examining relations of age and beta-amyloid with tau deposition measured using 18F-AV-1451 in cognitively normal older adults (2015) (0)
- PET IMAGING THROUGH THE COURSE OF ALZHEIMER'S DISEASE (2017) (0)
- Physiological imaging with PET and SPECT in Dementia (1989) (0)
- EXAMINING AMYLOID AND TAU INTER-REGIONAL PET ASSOCIATION PATTERNS IN COGNITIVELY NORMAL OLDER ADULTS (2016) (0)
- The pattern of cerebral hypometabolism and its association with clinical ratings in cognitively normal older adults with and without significant fibrillar amyloid burden: Findings from the Alzheimer's Disease Neuroimaging Initiative (2013) (0)
- The impact of beta-amyloid deposition and vascular risk factors on cortical thickness and cognition (2013) (0)
- Influence of rare RELN variants on quantitative PET imaging and CSF phenotypes in late-onset Alzheimer’s disease (2015) (0)
- Positive PIB-PET Is Associated with High Post-Mortem Amyloid Burden in Dementia Patients (P06.033) (2013) (0)
- P2-213 Selective reduction of medial temporal lobe NAA in cognitively impaired but non-demented elderly subjects (2004) (0)
- OP-BRAI120244 844..858 (2013) (0)
- S1-01-05: The current role of FDG-PET studies in dementia (2008) (0)
- P3-107 Folate, independent of homocysteine, is inversely associated with cognitive function and dementia in latino elderly: a report from the sacramento area latino study on aging (SALSA) (2004) (0)
- Rates of β-amyloid deposition indicate widespread simultaneous accumulation throughout the brain (2022) (0)
- Comparison of [11C]PIB and [18F]FDG PET in Discriminating Alzheimer's Disease and Frontotemporal Lobar Degeneration (2010) (0)
- IC-P-104 Imaging biomarkers to monitor treatment effects for Alzheimer’s disease trials: The Alzheimer’s disease imaging initiative (2006) (0)
- Relationships among biomarkers in early-stage Alzheimer's disease (AD): Findings in cognitively normal adults from the Alzheimer's Disease Neuroimaging Initiative (ADNI) (2013) (0)
- Alzheimer’s pathology is associated with dedifferentiation of functional memory networks in aging (2020) (0)
- Longitudinal gray matter changes in cognitively intact individuals with and without brain β-amyloid pathology (2015) (0)
- Wallace 2015 - Supplementary (2015) (0)
- Locus coeruleus catecholamines link neuroticism and vulnerability to tau pathology in aging (2022) (0)
- HUMAN IN VIVO TAU PATHOLOGY, IMPAIRED NREM SLEEP OSCILLATIONS AND MEMORY DECLINE IN AGING (2018) (0)
- PIB‐PET perfusion and FDG‐PET are highly correlated and similarly associated with cognitive performance (2022) (0)
- Validation of amyloid PET positivity thresholds in centiloids: a multisite PET study approach (2021) (0)
- b-Amyloid deposition in the human brain disrupts NREM slow wave sleep and associated hippocampus-dependent long term memory (2015) (0)
- Beta-amyloid deposition is related to default mode network connectivity in normal controls (2009) (0)
- Aging, amyloid and neural activity (2012) (0)
- Methylphenidate modifies the motion of the circadian clock Lamotrigine in mood disorders and cocaine dependence Cortical glutamate in postpartum depression Dopamine Synthesis Capacity is Associated with D 2 / 3 Receptor Binding but not Dopamine Release (2017) (0)
- 650 The role of positron emission tomography (PET) in determining the extent of CNS ischemia in sickle cell disease (SCD) (1996) (0)
- P2-198 Effects of age, cerebrovascular disease and APOE ε4 on entorhinal and hippocampal atrophy rates (2004) (0)
- A global resilience score captures associations with AD pathology and predicts cognitive decline in cognitively healthy older adults (2021) (0)
- Tau PET with [18F]AV1451 in non-alzheimer's disease neurodegenerative syndromes (2015) (0)
- Multivariate data analysis of FDG-PET and PiB-PET in three conditions with underlying Alzheimer's pathology (2012) (0)
- COMPARING LIBERAL AND CONSERVATIVE THRESHOLDS FOR AMYLOID PET POSITIVITY IN AUTOPSY-PROVEN CASES (2014) (0)
- TAU PATHOLOGY AND GRAY MATTER ATROPHY CONTRIBUTE TO COGNITIVE IMPAIRMENT IN ALZHEIMER’S DISEASE (2017) (0)
- Comparing predictors of conversion: Data from the Alzheimer's Disease Neuroimaging Initiative (2009) (0)
- Are low levels of PiB-PET signal clinically significant? (2015) (0)
- TAU PET IMAGING IN AGING: CONTRIBUTIONS TO COGNITIVE DECLINE AND NEURAL DYSFUNCTION (2019) (0)
- VASCULAR RISK FACTORS IMPACT COGNITION INDEPENDENT OF PIB PET AND MRI MEASURES OF AD AND VASCULAR BRAIN INJURY (2014) (0)
- Region-specific associations of brain glucose metabolism with age and beta-amyloid in normal aging (2013) (0)
- IRON, NEURODEGENERATION, TAU, AND AMYLOID IN PATIENTS WITH ALZHEIMER’S DISEASE (2019) (0)
- Association of gray matter atrophy with age, beta-amyloid, white matter hyperintensity and cognition in normal aging (2013) (0)
- SPATIAL CORRELATION BETWEEN GRAY MATTER CHANGES IN CHILDHOOD, FDG METABOLISM IN YOUNG ADULTS, AND BETA-AMYLOID DEPOSITION IN THE ELDERLY (2014) (0)
- SNAP: ALZHEIMER'S DISEASE PLUS OVERLAPPING NON-AD PATTERNS IN THE AGING BRAIN? (2016) (0)
- [ 18 F]Flortaucipir PET to autopsy pathology comparisons in Alzheimer’s disease and other neurodegenerative diseases: Biomarkers: Leveraging postmortem collections to validate neuroimaging (2020) (0)
- Brain Aβ amyloid measures and MRI are complimentary predictors of progression from MCI to Alzheimer's disease (2010) (0)
- INCREASED AMYLOID DEPOSITION IN OLDER ADULTS AT RISK FOR PROGRESSION TO ALZHEIMER'S DISEASE DUE TO GENETIC BACKGROUND AND/OR THE PRESENCE OF SIGNIFICANT MEMORY CONCERNS (2014) (0)
- PREDICTING FUTURE RATE OF COGNITIVE DECLINE DUE TO ALZHEIMER’S DISEASE (2019) (0)
- ASSOCIATIONS BETWEEN HIPPOCAMPAL AV-1451 DEPOSITION AND LIMBIC WHITE MATTER INTEGRITY IN NORMAL AGING (2017) (0)
- THE INFLUENCE OF DOPAMINE SYNTHESIS CAPACITY ON REWARD LEARNING AND INCIDENTAL ENCODING IN AGING (2019) (0)
- Whole brain MRI‐free tau and amyloid PET quantification (2022) (0)
- NREM SLOW WAVE ACTIVITY <1HZ AS A BIOMARKER AND LONG-TERM PREDICTOR OF B-AMYLOID BURDEN IN OLDER ADULTS (2016) (0)
- Apolipoprotein E ɛ4–related effects on cognition are limited to the Alzheimer’s disease spectrum (2021) (0)
- OBSTRUCTIVE SLEEP APNEA, BRAIN BETA-AMYLOID MEASURES AND TIME-TO-PROGRESSION FROM MILD COGNITIVE IMPAIRMENT TO ALZHEIMER’S DISEASE BETWEEN MEAN CORTICAL AMYLOID BURDEN AND REGIONAL GRAY MATTER REDUCTIONS IN ALZHEIMER’S DEMENTIA, MILD COGNITIVE IMPAIRMENT AND UNIMPAIRED OLDER ADULTS (2018) (0)
- Comparison of 18F‐Flortaucipir visual assessment, SUVR quantification and CSF pTau for defining T‐status in the AT(N) framework (2020) (0)
- Predicting Short-term MCI-to-AD Progression Using Imaging, CSF, Genetic Factors, Cognitive Resilience, and Demographics (2019) (0)
- Regional blood‐brain barrier breakdown and Alzheimer’s disease pathology in aging (2022) (0)
- PIB‐PET perfusion and FDG‐PET are highly correlated and similarly associated with cognitive performance (2022) (0)
- The diagnosis of dementia with single photon emission computed tomography (1987) (0)
- SPATIAL DISTRIBUTION AND TOPOGRAPHICAL RELATIONSHIPS OF PATHOLOGY AND NEURODEGENERATION IN ALZHEIMER’S DISEASE (2019) (0)
- LONGITUDINAL TAU-PET AND ATROPHY IN HEALTHY OLDER ADULTS AND IN ALZHEIMER’S DISEASE (2018) (0)
- IC-P2-086: The pattern of cerebral hypometablism in amnestic mild cognitive impairment and its relationship to subsequent conversion to probable Alzheimer's disease: Preliminary findings from the Alzheimer's disease neuroimaging initiative (2008) (0)
- Head to head comparison of [F] AV-1451 and [F] THK5351 for tau imaging in Alzheimer’s disease and frontotemporal dementia (2018) (0)
- Capitalizing on complementary FDG PET and florbetapir PET data sets to distinguish between early and late mild cognitive impairment using multi-modal partial least squares (2012) (0)
- Alzheimer’s pathology disrupts cortical processing of repeated stimuli in cognitively intact older adults (2022) (0)
- AV1451-PET UPTAKE AND CSF BIOMARKERS IN A HETEROGENEOUS CLINICAL SAMPLE: TWO SIDES OF THE SAME COIN? (2017) (0)
- Temporoparietal hypometabolism is common in FTLD and is associated with imaging diagnostic errors (2011) (0)
- Imaging in FTD (2012) (0)
- Validating PET Amyloid Imaging with Autopsy (2011) (0)
- Analytical and Clinical Performance of Amyloid-Beta Peptides Measurements in CSF of ADNIGO/2 Participants by an LC-MS/MS Reference Method. Running title: Amyloid beta in CSF of ADNIGO/2 participants (2020) (0)
- Worldwide ADNI Update – July , 2012 (2013) (0)
- Predicting Alzheimer Disease with Magnetic Resonance Imaging (2011) (0)
- Author Correction: FAM222A encodes a protein which accumulates in plaques in Alzheimer’s disease (2022) (0)
- O1-03-05 Improved classification of MCI and Alzheimer’s disease using diffusion tensor imaging of cingulum white matter (2006) (0)
- IC-P2-074: Differentiating amnestic MCI converting to probable AD from stable amnestic MCI using FDG-PET and an AD-related hypometabolism overlap index (2008) (0)
- F1-04-03 EFFECTS OFAGE AND TAUMEASURED IN CSF ONMNEMONIC DISCRIMINATION OF OBJECTS AND SCENES IN MEDIAL TEMPORAL LOBE PATHWAYS (2018) (0)
- NEURAL ACTIVITY REVEALED WITH FMRI IS RELATED TO BETA-AMYLOID AND TAU DEPOSITION IN HEALTHY AGING (2017) (0)
- Brain morphology, cognition, and b -amyloid in older adults with superior memory performance Neurobiology of Aging (2018) (0)
- ASSOCIATION OF [18F]AV-1451 TAU MARKERS WITH COGNITIVE AND NEURODEGENERATION MEASURES: PRELIMINARY ANALYSIS IN THE ADNI COHORT (2016) (0)
- Age at Onset and Single-Photon Emission Computed Tomographic Patterns of Regional Cerebral Blood Flow (2016) (0)
- TAU PATHOLOGY AND COGNITION ARE RELATED TO BASAL FOREBRAIN DEGENERATION IN AGING (2019) (0)
- P1-244: Frequency of hemispheric metabolic asymmetry in probable Alzheimer's disease (2008) (0)
- O4‐04‐06: Withdrawn (2015) (0)
- Perfusion imaging in the diagnosis of Alzheimer's disease: Clinical-pathological correlations (2000) (0)
- Brain multiplexes reveal morphological connectional biomarkers fingerprinting late brain dementia states (2018) (0)
- Genetic associations with brain amyloidosis (2020) (0)
- Longitudinal Effects of Cognitive Reserve and Vascular Risks in Aging and Dementia By Yen Yu Lo A dissertation submitted in partial satisfaction of the Requirements for the degree of Doctor of Philosophy (2012) (0)
- O3-01-05 Body fat distribution and brain structure (2004) (0)
- Abstract P3-11-01: Prospective study of cognitive function in women with early stage breast cancer: Predictors of cognitive decline and relationship to cognitive complaints (2013) (0)
- DIFFERENTIAL EFFECTS OF EARLY AND LATE-LIFE EXPERIENCES ON AMYLOID DEPOSITION VERSUS NEURODEGENERATION (2017) (0)
- SAMPLE SIZES FOR 24-MONTH ALZHEIMER’S PREVENTION TRIALS USING BIOMARKER ENDPOINTS IN COGNITIVELY UNIMPAIRED AMYLOID-POSITIVE ADULTS (2017) (0)
- Brain and cognitive correlates of subjective cognitive decline differ between healthy elderly with and without β-amyloid pathology (2015) (0)
- Use of an FDG-PET derived hypometabolic convergence index enrichment strategy to reduce sample sizes in Alzheimer's disease clinical trials: findings from the Alzheimer's Disease Neuroimaging Initiative (ADNI) (2011) (0)
- Imaging biomarkers in neurodegeneration: current and future practices (2020) (0)
- LONGITUDINAL TAU-PET AND ATROPHY IN HEALTHY OLDER ADULTS AND THOSE WITH ALZHEIMER’S DISEASE (2018) (0)
- Regional correlations between PiB-PET and postmortem burden of amyloid species (2015) (0)
- IC-02-02 DISCREPANCIES IN TAU AND b -AMYLOID BURDEN ARE FREQUENT ACROSS THE SPECTRUM OF NORMAL AGING AND ALZHEIMER’S DISEASE (2018) (0)
- Utility of amyloid PET in the differential diagnosis of dementia: An autopsy-confirmed series (2013) (0)
- SPATIAL DISTRIBUTION AND TOPOGRAPHICAL RELATIONSHIPS OF PATHOLOGY AND NEURODEGENERATION IN ALZHEIMER’S DISEASE (2019) (0)
- DIFFERENCE DWI AND CORTICAL IN THE ALZHEIMER’S DISEASE CONNECTOME PROJECT (2019) (0)
- CAVEATS WHEN SUBTRACTING TWO SERIAL MEASUREMENTS TO ESTIMATE THE NUMBER OF PARTICIPANTS NEEDED FOR CLINICAL TRIALS THAT ARE LONGER OR SHORTER THAN THE OBSERVED MEASUREMENT INTERVAL (2017) (0)
- ASSOCIATION OF [18F]AV-1451 TAU MARKERS WITH COGNITIVE AND NEURODEGENERATION MEASURES: PRELIMINARY ANALYSIS IN THE ADNI COHORT (2016) (0)
- TWO-YEAR LONGITUDINAL CHANGE IN AMYLOID DEPOSITION, GLUCOSE METABOLISM, AND HIPPOCAMPAL ATROPHY IN ADNI-2 PARTICIPANTS: RELATION TO GENETIC RISK (2014) (0)
- Use of an Alzheimer's Disease-Related Hypometabolic Convergence Index to Predict Progression from Mild Cognitive Impairment to Alzheimer's Dementia (2010) (0)
- Dementia and Its Causes (1995) (0)
- Gwas of longitudinal amyloid PET identifies IL1RAP as a new potential Alzheimer's disease target (2015) (0)
- Higher CSF sTREM2 attenuates ApoE4-related risk for cognitive decline and neurodegeneration (2020) (0)
- Definitions and characteristics of successful cognitive aging (2022) (0)
- Closer correlations between florbetapir PET measurements of amyloid plaque burden using a cerebral white matter reference region and Alzheimer’s disease‐related hypometabolism (2021) (0)
- [18F]Flortaucipir PET to autopsy pathology comparisons in Alzheimer’s disease and other neurodegenerative diseases (2020) (0)
- Effects of MRI markers of cerebrovascular disease on amyloid burden and cognition in aging (2011) (0)
- Associations of [18F]AV1451 Tau PET with age, ApoE genotype, and cognition in Alzheimer’s disease (2015) (0)
- PET and MRI in a community sample with cognitive impairment: The SALSA study (2000) (0)
- IC-P1-036: Categorical and correlational analyses of baseline fluorodeoxyglucose positron emission tomography images from the Alzheimer's disease neuroimaging initiative (2008) (0)
- Functional networks underlying the association between tau pathology and memory (2022) (0)
- INDIVIDUAL-BASED NETWORK ANALYSIS: A NOVEL APPROACH TO INVESTIGATE THE PATHOLOGICAL SPREAD OF PHF TAU USING GRAPH THEORY IN CLINICAL AND PRECLINICAL STAGES OF ALZHEIMER’S DISEASE (2019) (0)
- A blood-based signature of cerebrospinal fluid Aβ1–42 status (2019) (0)
- Use of an fdg-pet-derived hypometabolic convergence index enrichment strategy to reduce sample sizes in alzheimer's disease clinical trials: Findings from the Alzheimer's Disease Neuroimaging Initiative (ADNI) (2011) (0)
- A cross‐cohort cognitive composite for tracking changes in pre‐clinical and prodromal Alzheimer’s disease (2020) (0)
- Characterization of the behavioral and dysexecutive variants of Alzheimer's disease (2015) (0)
- EXISTING THRESHOLDS FOR PIB POSITIVITY ARE TOO HIGH (2014) (0)
- Association between the Alzheimer's disease-related hypometabolic convergence index and clinical ratings in cognitively normal older adults with and without significant fibrillar amyloid burden: Findings from the Alzheimer's Disease Neuroimaging Initiative (2013) (0)
- Markers of infection predict cognitive decline over four years (2006) (0)
- Multivariate data analysis of FDG-PET and PiB-PET in three conditions with underlying Alzheimer's pathology (2012) (0)
- RELATIONSHIP BETWEEN [18F]AV-1451 BINDING AND ANTECEDENT AMYLOID DEPOSITION, GLUCOSE HYPOMETABOLISM AND ATROPHY MEASURES: PRELIMINARY ANALYSIS IN THE ADNI COHORT (2016) (0)
- O1-04-05 Six-month cerebral metabolic declines in Alzheimer’s disease, amnestic mild cognitive impairment and elderly normal control groups: Preliminary findings from the Alzheimer’s disease neuroimaging initiative (2007) (0)
- PLASMA PTAU181 LEVELS REFLECT [18F]AV1451 TAU PET UPTAKE ACROSS THE TAUOPATHY SPECTRUM (2019) (0)
- A double-edged sword: the role of prior knowledge in memory across the adult lifespan (2021) (0)
- Regional patterns of brain N-acetyl aspartate differentiate Alzheimer's disease and vascular dementia (2000) (0)
- OPPORTUNITIES AND CHALLENGES FOR IMPLEMENTING ALZHEIMERS BIOMARKERS IN RESEARCH STUDIES (2017) (0)
- NORMAL COGNITION DESPITE VERY HIGH RISK FOR ALZHEIMER’S DISEASE: NEUROIMAGING AND NEUROPSYCHOLOGICAL INSIGHTS INTO RESILIENT BRAIN AGING (2016) (0)
- Restoration of Dopaminergic Activity in Parkinsonian Monkeys by Adeno-Associated Vector-mediated Gene Transfer of AADC (1999) (0)
- JAMA Paper supplement (2015) (0)
- DOES APOE ε4 HAVE AN Aβ-INDEPENDENT EFFECT ON TAU PATHOLOGY? NEUROIMAGING INVESTIGATIONS IN COGNITIVELY NORMAL ELDERS AND PATIENTS WITH ALZHEIMER’S DISEASE (2017) (0)
- P1-338: The consistency of hypometabolic brain voxels in probable Alzheimer's disease and amnestic mild cognitive impairment patients from the Alzheimer's disease neuroimaging initiative (2008) (0)
- Effect of Alzheimer’s pathology on the functional architecture of memory networks during rest and task states in aging (2021) (0)
- Serotonin Reuptake Inhibitors are Associated with Less Amyloid‐β Burden Spatial Extent in Military Veterans with only PTSD, but not with TBI or Comorbid PTSD/TBI: Preliminary PET Findings from ADNI‐DOD Project (2022) (0)
- Hippocampal volume loss is associated with increased A-beta levels in the precuneus in mild cognitive impairment (2009) (0)
- Relationships between tau deposition, cognition, and β-amyloid (2016) (0)
- Fibrillar Amyloid: Thinking Globally, Not Acting Locally (P5.021) (2015) (0)
- Everyday Cognition - 1 - Short title: Everyday Cognition The Measurement of Everyday Cognition (ECog): Scale Development and Psychometric Properties (2008) (0)
- Age, vascular disease, and Alzheimer’s disease pathologies in amyloid negative elderly adults (2021) (0)
- GenEpi: gene-based epistasis discovery using machine learning (2020) (0)
- THE INFLUENCE OF AGING AND TAU DEPOSITION ON MEMORY CONSOLIDATION USING A NOVEL ECOLOGICALLY VALID MEMORY TASK (2018) (0)
- Sensitivity of objective and subjective sleep features to tau and Aβ burden in healthy older adults (2020) (0)
- Title : Altered excitatory and inhibitory neuronal subpopulation parameters are distinctly associated with tau and amyloid in Alzheimer ' s disease (2022) (0)
- P2-254 Imaging biomarkers to monitor treatment effects for Alzheimer’s disease trials: The Alzheimer’s disease imaging initiative (2006) (0)
- Correction to: Relevance of biomarkers across different neurodegenerative diseases (2020) (0)
- SPATIAL CORRELATION BETWEEN GRAY MATTER CHANGES IN CHILDHOOD, FDG METABOLISM IN YOUNG ADULTS, AND BETA-AMYLOID DEPOSITION IN THE ELDERLY (2014) (0)
- Hippocampal volume loss is associated with increased A-beta levels in the precuneus in mild cognitive impairment (2009) (0)
- Tau heterogeneity in Aβ positive patients (2022) (0)
- Metacognition, cortical thickness, and tauopathy in aging (2021) (0)
- CSF p‐Tau/Aβ40 ratio predicts longitudinal hypometabolism and cognitive decline in amyloid‐negative elderly adults (2021) (0)
- Standardization of FDG-PET (2010) (0)
- Serum Lipids and Cerebral Amyloidosis in Persons with High Vascular Risk (S04.003) (2013) (0)
- IC-01-06: Amyloid and glucose metabolism in early versus late-onset AD: A comparative [11C]PIB and [18F]FDG PET study (2008) (0)
- EFFECTS OF BASELINE REGIONAL AMYLOID DEPOSITION PATTERNS ON SUBSEQUENT ACCUMULATION (2016) (0)
This paper list is powered by the following services:
Other Resources About William J. Jagust
What Schools Are Affiliated With William J. Jagust?
William J. Jagust is affiliated with the following schools:
